Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diseases of the Thyroid

Free Subscription Articles published in J Clin Endocrinol Metab Retrieve available abstracts of 345 articles: HTML format

Single Articles

September 2025
1. ISLAM MS, Louzada Neto RA, Bouviere J, Ahmed AE, et al
   Functional Domain Mapping of TPO: Insights from Six Variants in Sudanese Kindreds with Congenital Hypothyroidism.
   J Clin Endocrinol Metab. 2025 Sep 26:dgaf536. doi: 10.1210.
   PubMed     Abstract available
   
   
   
2. POZDEYEV N, White SL, Bell CC, Haugen BR, et al
   Artificial intelligence applications in thyroid cancer care.
   J Clin Endocrinol Metab. 2025 Sep 25:dgaf530. doi: 10.1210.
   PubMed     Abstract available
   
   
   
3. VALENCIAGA A, Liyanarachchi S, Brock PL, Ringel MD, et al
   Long-term outcomes of patients diagnosed with differentiated thyroid cancer in childhood and young adulthood.
   J Clin Endocrinol Metab. 2025 Sep 18:dgaf522. doi: 10.1210.
   PubMed     Abstract available
   
   
   
4. XU X, Zhang C, Wang G, Dong B, et al
   Correlation of TgAb With Clinicopathological Features and Unfavorable Efficacy of 131I Ablation in PTC.
   J Clin Endocrinol Metab. 2025;110:e3245-e3251.
   PubMed     Abstract available
   
   
   
5. MENEGHINI V, de Lima Beltrao FE, Golovko G, Watson RK, et al
   Adverse outcomes in patients with hypothyroidism undergoing bariatric surgery: A retrospective study using TriNetX.
   J Clin Endocrinol Metab. 2025 Sep 16:dgaf519. doi: 10.1210.
   PubMed     Abstract available
   
   
   
6. JONKLAAS J
   Safe optimization of thyroid hormone therapy.
   J Clin Endocrinol Metab. 2025 Sep 10:dgaf512. doi: 10.1210.
   PubMed    
   
   
   
7. VILLAGELIN D, Cooper DS
   Low Dose Methimazole in the Long-Term Management of Graves' Disease: Small doses, big benefits.
   J Clin Endocrinol Metab. 2025 Sep 10:dgaf503. doi: 10.1210.
   PubMed    
   
   
   
8. WEI M, Mehravar S, Leite G, Naji P, et al
   Relationship between hypothyroidism, risk of small intestinal bacterial overgrowth, and duodenal microbiome alterations.
   J Clin Endocrinol Metab. 2025 Sep 5:dgaf495. doi: 10.1210.
   PubMed     Abstract available
   
   
   
9. REDLICH A, Pfaehler E, Kunstreich M, Schmutz M, et al
   ML Prediction of Recurrence in Pediatric Thyroid Cancer: MET Cohort Analysis Using XGBoost and SHAP.
   J Clin Endocrinol Metab. 2025 Sep 1:dgaf487. doi: 10.1210.
   PubMed     Abstract available
   
   
   August 2025
10. CHUBB SAP, Davis WA, Davis TME
    Effects of subclinical hypothyroidism on nephropathy complicating type 2 diabetes: The Fremantle Diabetes Study Phase II.
    J Clin Endocrinol Metab. 2025 Aug 29:dgaf485. doi: 10.1210.
    PubMed     Abstract available
    
    
    
11. CHO YY, Ahn SH, Kim M, Lee EK, et al
    TSH Cut-Offs and Recurrence Risk in Differentiated Thyroid Carcinomas: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2025 Aug 14:dgaf463. doi: 10.1210.
    PubMed     Abstract available
    
    
    
12. YANG L, Sato M, Saito-Abe M, Miyaji Y, et al
    Association Between Particulate Matter Exposure and Thyroid Hormone Levels in Early Childhood: Results from JECS.
    J Clin Endocrinol Metab. 2025 Aug 6:dgaf446. doi: 10.1210.
    PubMed     Abstract available
    
    
    
13. MIYAMURA K, Ito M, Yamaoka H, Hisakado M, et al
    Impact of minimal dose strategy before anti-thyroid drug discontinuation on relapse risk in Graves' disease.
    J Clin Endocrinol Metab. 2025 Aug 1:dgaf433. doi: 10.1210.
    PubMed     Abstract available
    
    
    July 2025
14. XU Y, Licher S, Visser WE, Bakker SJL, et al
    Thyroid function and all-cause mortality in the context of multimorbidity: results from two population-based studies.
    J Clin Endocrinol Metab. 2025 Jul 25:dgaf425. doi: 10.1210.
    PubMed     Abstract available
    
    
    
15. NAKHLEH A, Robenshtok E, Adler L, Ben David SS, et al
    Clinical Characteristics and Outcomes of Graves' Disease in Individuals with Prior Hypothyroidism.
    J Clin Endocrinol Metab. 2025 Jul 25:dgaf426. doi: 10.1210.
    PubMed     Abstract available
    
    
    
16. LONG X
    Letter to the Editor from Long: "Assessing the Cardiovascular Effects of Levothyroxine Use in an Ageing United Kingdom Population (ACEL-UK): Cohort Study".
    J Clin Endocrinol Metab. 2025 Jul 21:dgaf419. doi: 10.1210.
    PubMed    
    
    
    
17. 
    Correction to: "Efficacy and Safety of Targeted Therapy for Radioiodine-Refractory Differentiated Thyroid Cancer".
    J Clin Endocrinol Metab. 2025 Jul 21:dgaf407. doi: 10.1210.
    PubMed    
    
    
    
18. CHIARDI I, Croce L, Caccavale P, Bertini J, et al
    Establishing the adequate levothyroxine dose after total thyroidectomy: A systematic review with meta-analysis.
    J Clin Endocrinol Metab. 2025 Jul 19:dgaf417. doi: 10.1210.
    PubMed     Abstract available
    
    
    
19. MAINO F, Mattii E, Castagna MG
    Letter to the Editor from Maino et al.: "Prevalence and Management of Complications of Laser Ablation for Benign Thyroid Nodules: A Systematic Review of Literature and Meta-Analysis".
    J Clin Endocrinol Metab. 2025 Jul 18:dgaf411. doi: 10.1210.
    PubMed    
    
    
    
20. SCAPPATICCIO L, Di Martino N, Ferrazzano P, Maiorino MI, et al
    Response to Letter to the Editor from Maino et al.: "Prevalence and Management of Complications of Laser Ablation for Benign Thyroid Nodules: A Systematic Review of Literature and Meta-Analysis".
    J Clin Endocrinol Metab. 2025 Jul 18:dgaf412. doi: 10.1210.
    PubMed    
    
    
    
21. GREENSPUN BC, Metzger DA, Lee S, Pearson BE, et al
    Long Term Survivors of Anaplastic Thyroid Cancer: A Genomic Predictive Model.
    J Clin Endocrinol Metab. 2025 Jul 15:dgaf391. doi: 10.1210.
    PubMed     Abstract available
    
    
    
22. BODOQUE-CUBAS J, Fernandez-Saez J, Martinez-Hervas S, Perez-Lacasta MJ, et al
    Integrating Artificial Intelligence in Thyroid Nodule Management: Clinical Outcomes and Cost-Effectiveness Analysis.
    J Clin Endocrinol Metab. 2025 Jul 12:dgaf399. doi: 10.1210.
    PubMed     Abstract available
    
    
    
23. ETTLESON MD, Thomas N, Ramirez M, Wan W, et al
    Measuring hypothyroidism disease control using a TSH-based "time-in-range".
    J Clin Endocrinol Metab. 2025 Jul 12:dgaf393. doi: 10.1210.
    PubMed     Abstract available
    
    
    
24. 
    Correction to: "Medullary Thyroid Cancer: Single Institute Experience Over 3 Decades and Risk Factors for Recurrence".
    J Clin Endocrinol Metab. 2025 Jul 3:dgaf380. doi: 10.1210.
    PubMed    
    
    
    June 2025
25. HAMIDI S, Maniakas A, Akhave NS, Banuchi VE, et al
    Characterization of advanced RAS-driven follicular-derived thyroid cancers and review of future therapeutic avenues.
    J Clin Endocrinol Metab. 2025 Jun 26:dgaf366. doi: 10.1210.
    PubMed     Abstract available
    
    
    
26. BELTRAO FEL, Carvalhal G, Meneghini V, Matos DAR, et al
    Treatment of Hypothyroidism that Contains Liothyronine is Associated with Reduced Risk of Dementia and Mortality.
    J Clin Endocrinol Metab. 2025 Jun 20:dgaf367. doi: 10.1210.
    PubMed     Abstract available
    
    
    
27. KIZILGUL M, Yigit T, Ata N, Celik A, et al
    Machine Learning Prediction of Pancreatitis Risk With Antithyroid Drugs: A Nationwide Retrospective Observational Study.
    J Clin Endocrinol Metab. 2025;110:2024-2030.
    PubMed     Abstract available
    
    
    
28. MULDER TA, Muetzel RL, Peeters RP, Tiemeier H, et al
    Maternal thyroid function during pregnancy and early adolescent regional differences in cerebral gray matter morphology.
    J Clin Endocrinol Metab. 2025 Jun 16:dgaf349. doi: 10.1210.
    PubMed     Abstract available
    
    
    
29. SUGISAWA C, Uehara E, Tanase-Nakao K, Inoue K, et al
    Clinical and Genetic Characteristics of Adult Nonautoimmune Hypothyroidism: A Single-Institution Study.
    J Clin Endocrinol Metab. 2025 Jun 12:dgaf352. doi: 10.1210.
    PubMed     Abstract available
    
    
    
30. TOLOZA FJK, Gummalla S, Maraka S
    Levothyroxine in Pregnancy: Protective Neurodevelopmental Role Beyond Cognitive Outcomes?
    J Clin Endocrinol Metab. 2025 Jun 11:dgaf351. doi: 10.1210.
    PubMed    
    
    
    
31. HEDBERG F, Lindh JD, Mannheimer B, Planck T, et al
    Influence of Preexisting Psychiatric Morbidity on Liothyronine Use in Hypothyroidism: A Swedish Nationwide Cohort Study.
    J Clin Endocrinol Metab. 2025 Jun 7:dgaf337. doi: 10.1210.
    PubMed     Abstract available
    
    
    
32. YAMAZAKI H, Sugino K, Katoh R, Matsuzu K, et al
    Clinical Significance of Successful Ablation in Follicular Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2025 Jun 4:dgaf326. doi: 10.1210.
    PubMed     Abstract available
    
    
    
33. KU EJ, Lee J, Yoo WS, Bae J, et al
    Response to Letter to the Editor From Yan and Chang: "Long-Term Non-skeletal Complications in Patients with Thyroid Cancer and Hypoparathyroidism Post-total Thyroidectomy".
    J Clin Endocrinol Metab. 2025 Jun 2:dgaf317. doi: 10.1210.
    PubMed    
    
    
    
34. YAN B, Chang S
    Letter to the Editor from Yan and Chang: "Long-Term Non-skeletal Complications in Patients with Thyroid Cancer and Hypoparathyroidism Post-total Thyroidectomy".
    J Clin Endocrinol Metab. 2025 Jun 2:dgaf316. doi: 10.1210.
    PubMed    
    
    
    May 2025
35. NISHIKAWA Y, Oguro F, Suzuki C, Kobashi Y, et al
    Stable iodine intake and thyroid screening outcomes after the Fukushima Nuclear Disaster: an observational study.
    J Clin Endocrinol Metab. 2025 May 29:dgaf312. doi: 10.1210.
    PubMed     Abstract available
    
    
    
36. FRICH PS, Sigstad E, Berstad AE, Opsahl EM, et al
    Ethanol Ablation of Metastatic Lymph Nodes in Patients with Papillary Thyroid Carcinoma - Predictors of Clinical Outcome.
    J Clin Endocrinol Metab. 2025 May 23:dgaf298. doi: 10.1210.
    PubMed     Abstract available
    
    
    
37. THOMSEN MJ, Uldall Torp NM, Carle A, Karmisholt J, et al
    Hypothyroidism in Danish pregnant women across decades.
    J Clin Endocrinol Metab. 2025 May 21:dgaf300. doi: 10.1210.
    PubMed     Abstract available
    
    
    
38. YIN Q, Zhu T, Song D, Fang S, et al
    Soluble Immune Checkpoints Associated With Disease Activity and Treatment Response in GD and TED.
    J Clin Endocrinol Metab. 2025;110:1537-1549.
    PubMed     Abstract available
    
    
    
39. JING G, Tang J, Li Y, Li Y, et al
    Thyrotrophin receptor antibody: objective and quantitative inflammatory indicator in patients with thyroid eye disease.
    J Clin Endocrinol Metab. 2025 May 9:dgaf273. doi: 10.1210.
    PubMed     Abstract available
    
    
    
40. MCNABB CB, Scholz A, Bloomfield L, Bhargava R, et al
    Controlled Antenatal Thyroid Screening Study III: Effects of gestational thyroid status on brain microstructure.
    J Clin Endocrinol Metab. 2025 May 9:dgaf277. doi: 10.1210.
    PubMed     Abstract available
    
    
    
41. GAO Y, Du C, Xu Y, Cheng X, et al
    Optimal Levothyroxine Dosing Strategy for Immune Checkpoint Inhibitor-Related Hypothyroidism: A Retrospective Study.
    J Clin Endocrinol Metab. 2025 May 3:dgaf260. doi: 10.1210.
    PubMed     Abstract available
    
    
    April 2025
42. BUJNIS M, DeSalvo K, Neklason DW, Madsen MJ, et al
    Familial risk of Hashimoto's thyroiditis in a large genealogical database.
    J Clin Endocrinol Metab. 2025 Apr 28:dgaf251. doi: 10.1210.
    PubMed     Abstract available
    
    
    
43. WHITE SL, Jamil T, Bell C, Fishbein L, et al
    Population prevalence of the major thyroid cancer-associated syndromes.
    J Clin Endocrinol Metab. 2025 Apr 15:dgaf236. doi: 10.1210.
    PubMed     Abstract available
    
    
    
44. HIRUMA S, Watanabe N, Noh JY, Hirose R, et al
    Occurrence of Newly Diagnosed Thyroid Cancer Is Not Increased After Radioactive Iodine Therapy for Graves' Disease.
    J Clin Endocrinol Metab. 2025 Apr 11:dgaf231. doi: 10.1210.
    PubMed     Abstract available
    
    
    
45. ZHANG M, Qi X, Zhou X, Liu Y, et al
    A preclinical state of Graves' ophthalmopathy characterized by hypoxia of T-cells identified via multi-omics analysis.
    J Clin Endocrinol Metab. 2025 Apr 11:dgaf230. doi: 10.1210.
    PubMed     Abstract available
    
    
    
46. KONDA B, Sherman EJ, Massarelli E, Nieva J, et al
    Response to Letter to the Editor from Zhang et al.: Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer.
    J Clin Endocrinol Metab. 2025 Apr 4:dgaf221. doi: 10.1210.
    PubMed    
    
    
    
47. ZHANG Y, Zhao Y, Deng T, Meng W, et al
    Letter to the Editor from Zhang et al.: 'Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer'.
    J Clin Endocrinol Metab. 2025 Apr 4:dgaf220. doi: 10.1210.
    PubMed    
    
    
    
48. HOLLEY M, Razvi S, Maxwell I, Dew R, et al
    Assessing the Cardiovascular Effects of Levothyroxine Use in an Ageing United Kingdom population (ACEL-UK): Cohort Study.
    J Clin Endocrinol Metab. 2025 Apr 3:dgaf208. doi: 10.1210.
    PubMed     Abstract available
    
    
    
49. KIM MH, Lee J, Lim DJ, Ishikawa KM, et al
    Thyroid Hormone Sensitivity as a Possible Determinant of Metabolic Phenotypes in Young Adults, Not in the Elderly.
    J Clin Endocrinol Metab. 2025 Apr 3:dgaf214. doi: 10.1210.
    PubMed     Abstract available
    
    
    
50. KU EJ, Lee J, Yoo WS, Bae J, et al
    Long-Term Non-skeletal Complications in Patients with Thyroid Cancer and Hypoparathyroidism Post-total Thyroidectomy.
    J Clin Endocrinol Metab. 2025 Apr 2:dgaf213. doi: 10.1210.
    PubMed     Abstract available
    
    
    
51. DE LEO S, Brigante G, D'Elia S, Censi S, et al
    Prospective Validation of ATA Risk Score for Papillary Thyroid Microcarcinoma: An ITCO Real-World Study.
    J Clin Endocrinol Metab. 2025 Apr 1:dgaf190. doi: 10.1210.
    PubMed     Abstract available
    
    
    March 2025
52. 
    Correction to: "Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer".
    J Clin Endocrinol Metab. 2025 Mar 27:dgaf185. doi: 10.1210.
    PubMed    
    
    
    
53. SHARIQ OA, Waguespack SG, Hamidi S, Kensing BC, et al
    Approach to the Patient: Hereditary Medullary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2025 Mar 19:dgaf089. doi: 10.1210.
    PubMed     Abstract available
    
    
    
54. 
    Correction to: "Natural History of Cytologically Low-Risk Indeterminate Thyroid Nodules".
    J Clin Endocrinol Metab. 2025 Mar 14:dgaf162. doi: 10.1210.
    PubMed    
    
    
    
55. UWUMIRO F, Arji E, Okpujie V, Asaju F, et al
    National Trends in U.S Hospitalizations and Outcomes of Thyrotoxicosis With and Without Thyrotoxic Storm, 2016-2020.
    J Clin Endocrinol Metab. 2025 Mar 11:dgaf150. doi: 10.1210.
    PubMed     Abstract available
    
    
    
56. BERGMAN D, Kang X, Sun J, Ebrahimi F, et al
    Autoimmune Thyroid Diseases and Microscopic Colitis: A Nationwide Matched Case-Control Study in Sweden.
    J Clin Endocrinol Metab. 2025 Mar 5:dgaf140. doi: 10.1210.
    PubMed     Abstract available
    
    
    
57. AEKKA A, Arva NC, Ren HZ, Raval M, et al
    Multiplatform Molecular Testing as an Adjunct to Fine Needle Aspiration in the Evaluation of Pediatric Thyroid Nodules.
    J Clin Endocrinol Metab. 2025 Mar 4:dgaf110. doi: 10.1210.
    PubMed     Abstract available
    
    
    
58. GATTA E, Pirola I, Gotti A, Fredi M, et al
    Clinical phenotype of Graves' disease in Autoimmune Polyglandular Syndrome or as isolated disease: the GRAPHE study.
    J Clin Endocrinol Metab. 2025 Mar 1:dgaf144. doi: 10.1210.
    PubMed     Abstract available
    
    
    February 2025
59. JIA Y, Wang X, Zhang L, Duan Y, et al
    Common and Rare DUOX Variants in Patients with Congenital Hypothyroidism: Case-control Study and Family-based Analysis.
    J Clin Endocrinol Metab. 2025 Feb 24:dgaf109. doi: 10.1210.
    PubMed     Abstract available
    
    
    
60. SCAPPATICCIO L, Di Martino N, Ferrazzano P, Maiorino MI, et al
    Prevalence and Management of Complications of Laser Ablation for Benign Thyroid Nodules: A Systematic Review of Literature and Meta-analysis.
    J Clin Endocrinol Metab. 2025 Feb 20:dgaf108. doi: 10.1210.
    PubMed     Abstract available
    
    
    
61. LAI ST, Bauer AJ
    Approach to the Pediatric Patient with Thyroid Nodules.
    J Clin Endocrinol Metab. 2025 Feb 13:dgaf090. doi: 10.1210.
    PubMed     Abstract available
    
    
    
62. 
    Correction to: "Associations Between Subclinical Thyroid Dysfunction and Cardiovascular Risk Factors According to Age and Sex".
    J Clin Endocrinol Metab. 2025 Feb 11:dgaf061. doi: 10.1210.
    PubMed    
    
    
    
63. ZHOU J, Li D, Ren J, Huang C, et al
    Machine Learning: A Multicentre Study on Predicting Lateral Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2025 Feb 8:dgaf070. doi: 10.1210.
    PubMed     Abstract available
    
    
    
64. WANG L, Zhang L, Ma R, Zhang Y, et al
    Semaglutide reprograms macrophages via the GLP-1R/PPARG/ACSL1 pathway to suppress papillary thyroid carcinoma growth.
    J Clin Endocrinol Metab. 2025 Feb 5:dgaf053. doi: 10.1210.
    PubMed     Abstract available
    
    
    
65. JIANG L, Zhou L, Liu J, Wang Y, et al
    Sex Differences in the Association Between Thyroid Hormone Sensitivity and Cardiovascular-Kidney-Metabolic Syndrome.
    J Clin Endocrinol Metab. 2025 Feb 4:dgaf059. doi: 10.1210.
    PubMed     Abstract available
    
    
    
66. CIRELLO V, Colombo C, Tosi D, Manzo A, et al
    TP53 Alterations Associate with Poor Response to Lenvatinib in Patients with Advanced Thyroid Cancer.
    J Clin Endocrinol Metab. 2025 Feb 1:dgaf056. doi: 10.1210.
    PubMed     Abstract available
    
    
    January 2025
67. CHENG KL, Yu WS, Wang YH, Ibarburu GH, et al
    Long-term Thyroid Outcomes After COVID-19 Vaccination: A Cohort Study of 2,333,496 Patients from the TriNetX Network.
    J Clin Endocrinol Metab. 2025 Jan 30:dgaf064. doi: 10.1210.
    PubMed     Abstract available
    
    
    
68. VAN DER MEEREN MMD, Boers T, de Graaf P, Duvivier KM, et al
    Radiofrequency ablation for thyroid nodules (RATED study) - analysis of a learning curve and predictors of success.
    J Clin Endocrinol Metab. 2025 Jan 29:dgaf058. doi: 10.1210.
    PubMed     Abstract available
    
    
    
69. TELITI M, Chytiris S, Coperchini F, Cerutti M, et al
    The natural history of cytologically low-risk indeterminate thyroid nodules.
    J Clin Endocrinol Metab. 2025 Jan 29:dgaf052. doi: 10.1210.
    PubMed     Abstract available
    
    
    
70. CHOE HJ, Choi YM, Ha Y, Kim J, et al
    The Role of the Parametric Thyroid Feedback Quantile Index in Cardiovascular Risk Evaluation Among Euthyroid Koreans.
    J Clin Endocrinol Metab. 2025 Jan 22:dgaf046. doi: 10.1210.
    PubMed     Abstract available
    
    
    
71. ORTH HM, Killer A, Gliga S, Bohm M, et al
    Subacute thyroiditis - Is it really linked to viral infection? Retrospective hospital patient registry study.
    J Clin Endocrinol Metab. 2025 Jan 15:dgaf023. doi: 10.1210.
    PubMed     Abstract available
    
    
    
72. 
    Correction to: "Effect of Waiting Time for Radioactive Iodine Therapy on Outcome in N1 Stage Papillary Thyroid Cancer".
    J Clin Endocrinol Metab. 2025 Jan 11:dgae900. doi: 10.1210.
    PubMed    
    
    
    
73. STOUPA A, Kariyawasam D, Jabot-Hanin F, Quoc AN, et al
    Digenic Inheritance Mode in Congenital Hypothyroidism due to Thyroid Dysgenesis: HYPOTYGEN translational cohort study.
    J Clin Endocrinol Metab. 2025 Jan 9:dgaf004. doi: 10.1210.
    PubMed     Abstract available
    
    
    
74. BARTALENA L, Smith TJ
    Treatment of Hyperthyroidism in Graves' Disease Complicated by Thyroid Eye Disease.
    J Clin Endocrinol Metab. 2025 Jan 9:dgaf009. doi: 10.1210.
    PubMed     Abstract available
    
    
    
75. ROBENSHTOK E, Bachar G, Ritter A
    Approach to the Patient with Thyroid Cancer: Selection and Management of Candidates for Lobectomy.
    J Clin Endocrinol Metab. 2025 Jan 2:dgae903. doi: 10.1210.
    PubMed     Abstract available
    
    
    
76. ORSOS I, Molnar Z, Ujhelyi B, Steiber Z, et al
    Stimulation of Piezo1 mechanosensitive channels inhibits adipogenesis in thyroid eye disease.
    J Clin Endocrinol Metab. 2025 Jan 2:dgae899. doi: 10.1210.
    PubMed     Abstract available
    
    
    December 2024
77. PENG R, Xie P, Jin Z, Zhou W, et al
    Significance of Thyroid Stimulating Immunoglobulin and Thyrotropin Receptor Antibody in Graves' Disease.
    J Clin Endocrinol Metab. 2024 Dec 23:dgae892. doi: 10.1210.
    PubMed     Abstract available
    
    
    
78. HUANG J, Su A, Yang J, Zhuang W, et al
    Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment.
    J Clin Endocrinol Metab. 2024;110:159-165.
    PubMed     Abstract available
    
    
    
79. YU B, Wang Y, Jin J, Liu J, et al
    CD34+ orbital fibroblasts contribute to the pathogenesis of thyroid eye disease via miR-182-5p.
    J Clin Endocrinol Metab. 2024 Dec 18:dgae876. doi: 10.1210.
    PubMed     Abstract available
    
    
    
80. XU Y, Liu R, Huang L, Qin Y, et al
    Comprehensive Comparisons of Different Treatments for Active Graves' Orbitopathy: A Systematic Review and Bayesian Model-Based Network Meta-Analysis.
    J Clin Endocrinol Metab. 2024 Dec 16:dgae877. doi: 10.1210.
    PubMed     Abstract available
    
    
    
81. RAZVI SS, Wild H, Ingoe L, Vernazza J, et al
    Changes in thyroid function and autoimmunity in older individuals: longitudinal analysis of the Whickham cohort.
    J Clin Endocrinol Metab. 2024 Dec 14:dgae875. doi: 10.1210.
    PubMed     Abstract available
    
    
    
82. BARETELLA O, Blum MR, Abolhassani N, Alwan H, et al
    Associations between subclinical thyroid dysfunction and cardiovascular risk factors according to age and sex.
    J Clin Endocrinol Metab. 2024 Dec 12:dgae860. doi: 10.1210.
    PubMed     Abstract available
    
    
    
83. CHENG Y, Hu H, Li W, Nie S, et al
    Chronic kidney disease and thyroid hormones.
    J Clin Endocrinol Metab. 2024 Dec 9:dgae841. doi: 10.1210.
    PubMed     Abstract available
    
    
    
84. BEA S, Ahn HY, Woo J, Shin JY, et al
    The Impact of COVID-19 Vaccination on Thyroid Disease in 7 Million Adult and 0.2 Million Adolescent Vaccine Recipients.
    J Clin Endocrinol Metab. 2024 Dec 9:dgae858. doi: 10.1210.
    PubMed     Abstract available
    
    
    
85. GUO Y, Liu B, Liang W, Cheng Y, et al
    2'-O-Galloylhyperin Prevents Tissue Remodeling in Thyroid Eye Disease: Prospects as a Thyrotropin Receptor Antagonist.
    J Clin Endocrinol Metab. 2024 Dec 2:dgae732. doi: 10.1210.
    PubMed     Abstract available
    
    
    November 2024
86. WEI Y, Yang M, Liu J, Wang Y, et al
    Associations between Sensitivity to Thyroid Hormones and Visceral Adiposity in Euthyroid Adults.
    J Clin Endocrinol Metab. 2024 Nov 18:dgae806. doi: 10.1210.
    PubMed     Abstract available
    
    
    
87. YU X, Liu Y, Wang M, Jia P, et al
    Association between per- and polyfluoroalkyl substance exposures and thyroid homeostasis parameters.
    J Clin Endocrinol Metab. 2024 Nov 18:dgae798. doi: 10.1210.
    PubMed     Abstract available
    
    
    
88. CHEN Z, Sun W, Fei M, Qian K, et al
    Clinical and Sonographic Differences between RET Fusion-Positive and BRAFV600E in Papillary Thyroid Carcinoma.
    J Clin Endocrinol Metab. 2024 Nov 18:dgae803. doi: 10.1210.
    PubMed     Abstract available
    
    
    
89. SCHUMM MA, Nikiforov YE, Nikiforova MN, Wald AI, et al
    Association of BRAF V600E allele frequency with clinicopathologic outcomes in papillary thyroid cancer.
    J Clin Endocrinol Metab. 2024 Nov 14:dgae774. doi: 10.1210.
    PubMed     Abstract available
    
    
    
90. SHI B, Liu Z, Zhang R, Tiemuerniyazi X, et al
    Subclinical hypothyroidism as an independent predictor of cardiovascular prognosis in left ventricular thrombus patients.
    J Clin Endocrinol Metab. 2024 Nov 11:dgae793. doi: 10.1210.
    PubMed     Abstract available
    
    
    
91. WANG H, Li W, Chang P, Jia Q, et al
    Effect of methimazole withdrawl period on the I-131 uptake estimation using Tc-99m thyroid scanning in Graves' disease.
    J Clin Endocrinol Metab. 2024 Nov 11:dgae794. doi: 10.1210.
    PubMed     Abstract available
    
    
    
92. 
    Correction to: "Prognostic Analysis of 131I Efficacy After Papillary Thyroid Carcinoma Surgery Based on CT Radiomics".
    J Clin Endocrinol Metab. 2024 Nov 1:dgae756. doi: 10.1210.
    PubMed    
    
    
    October 2024
93. MENG L, Li H, Fu Y, Yu D, et al
    Somatic DICER1-Mutant Benign Thyroid Nodules in Adults: A Group of Follicular Nodular Disease With Continuous Growth.
    J Clin Endocrinol Metab. 2024 Oct 28:dgae750. doi: 10.1210.
    PubMed     Abstract available
    
    
    
94. KIM J, Shin J, Kim MS, Moon JH, et al
    Cost-Effectiveness Analysis Comparing Conventional and Digital Software Supported Management for Hypothyroidism.
    J Clin Endocrinol Metab. 2024 Oct 24:dgae751. doi: 10.1210.
    PubMed     Abstract available
    
    
    
95. PARVATHAREDDY SK, Siraj AK, Qadri Z, Siraj N, et al
    The Prognostic Impact of Tumor Size and BRAF Mutational Status in Middle Eastern Differentiated Thyroid Cancer.
    J Clin Endocrinol Metab. 2024 Oct 18:dgae740. doi: 10.1210.
    PubMed     Abstract available
    
    
    
96. 
    Correction to: "Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine".
    J Clin Endocrinol Metab. 2024 Oct 16:dgae717. doi: 10.1210.
    PubMed    
    
    
    
97. 
    Correction to: "Effects of Low-dose Methotrexate With Methimazole in Patients With Graves' Disease: Results of a Randomized Clinical Trial".
    J Clin Endocrinol Metab. 2024 Oct 16:dgae698. doi: 10.1210.
    PubMed    
    
    
    
98. BEHAIRY N, Leonardi AJ, Gubbi S, Kumari S, et al
    Tumor Volume Doubling Time of Less Than One Year is Associated with a Higher Risk of Death from Medullary Thyroid Cancer.
    J Clin Endocrinol Metab. 2024 Oct 16:dgae733. doi: 10.1210.
    PubMed     Abstract available
    
    
    
99. SUN A, Wang X, Qu J, Wu Y, et al
    The efficacy and safety of intravenous tocilizumab to treat Graves' ophthalmopathy: A systematic review and single-arm meta-analysis.
    J Clin Endocrinol Metab. 2024 Oct 14:dgae711. doi: 10.1210.
    PubMed     Abstract available
    
    
    
100. KELLY CA, Sipos JA
     Approach to the patient with thyroid nodules: considering GLP-1 receptor agonists.
     J Clin Endocrinol Metab. 2024 Oct 14:dgae722. doi: 10.1210.
     PubMed     Abstract available
     
     
     
101. LEE S, Antunez AG, Sinco B, Saucke MC, et al
     Cancer-related Fear and Worry in Patients with Low-Risk Thyroid Cancer: A Longitudinal Cohort Study.
     J Clin Endocrinol Metab. 2024 Oct 14:dgae688. doi: 10.1210.
     PubMed     Abstract available
     
     
     
102. PHAM-DOBOR G, Kaltenecker P, Temesfoi V, Bajnok L, et al
     Systematic analysis and network mapping of disease associations in autoimmune polyglandular syndrome.
     J Clin Endocrinol Metab. 2024 Oct 8:dgae701. doi: 10.1210.
     PubMed     Abstract available
     
     
     
103. NISHIHARA E, Fukata S, Hirokawa M, Higuchi M, et al
     Nodule-specific NRF2-targeted upregulation in patients with KEAP1 mutations and familial nontoxic multinodular goiter.
     J Clin Endocrinol Metab. 2024 Oct 7:dgae699. doi: 10.1210.
     PubMed     Abstract available
     
     
     
104. HSU YC, Kuo CY, Chien MN, Jhuang JY, et al
     Overexpression of NR1D1 portends disease recurrence in thyroid cancer.
     J Clin Endocrinol Metab. 2024 Oct 3:dgae687. doi: 10.1210.
     PubMed     Abstract available
     
     
     
105. MEHANNA H, Nankivell P, Boelaert K, Woolley R, et al
     Diagnostic performance of ultrasound vs. ultrasound-guided FNAc in thyroid nodules: data from the ElaTION trial.
     J Clin Endocrinol Metab. 2024 Oct 3:dgae682. doi: 10.1210.
     PubMed     Abstract available
     
     
     
106. ROTONDI M, Endo M, Teliti M, Crescenzi A, et al
     Beyond malignancy risk stratification: FNAC report anticipates thyroid cancer staging. Insights from recent studies.
     J Clin Endocrinol Metab. 2024 Oct 1:dgae675. doi: 10.1210.
     PubMed     Abstract available
     
     
     September 2024
107. MULDER TA, Guxens M, Rebagliato ML, Dineva M, et al
     Association of maternal thyroglobulin with gestational thyroid function and offspring IQ and brain morphology.
     J Clin Endocrinol Metab. 2024 Sep 27:dgae679. doi: 10.1210.
     PubMed     Abstract available
     
     
     
108. MORETTI S, Mandarano M, Menicali E, Guzzetti M, et al
     Wnt/B-catenin activation and TP53 mutations associate with distinct immune profiles in advanced thyroid cancer.
     J Clin Endocrinol Metab. 2024 Sep 27:dgae667. doi: 10.1210.
     PubMed     Abstract available
     
     
     
109. XU B, Baine MK, Jungbluth A, Alabkaa A, et al
     Detection of SEZ6, a therapeutic target, in medullary thyroid carcinoma.
     J Clin Endocrinol Metab. 2024 Sep 26:dgae672. doi: 10.1210.
     PubMed     Abstract available
     
     
     
110. ROBENSHTOK E
     Selective Use of Radioiodine in Pediatric Thyroid Cancer - A Paradigm Shift.
     J Clin Endocrinol Metab. 2024 Sep 21:dgae656. doi: 10.1210.
     PubMed    
     
     
     
111. ZHANG Y, Zhang X, Lin L, Xing M, et al
     Efficacy and safety of targeted therapy for radioiodine-refractory differentiated thyroid cancer: a meta-analysis.
     J Clin Endocrinol Metab. 2024 Sep 18:dgae617. doi: 10.1210.
     PubMed     Abstract available
     
     
     
112. MACIEL AAW, Danilovic DLS, Soares IC, Freitas TC, et al
     Association between papillary thyroid cancer and primary aldosteronism in individuals with hypertension.
     J Clin Endocrinol Metab. 2024 Sep 18:dgae653. doi: 10.1210.
     PubMed     Abstract available
     
     
     
113. DE LIMA BELTRAO FE, Carvalhal G, de Almeida Beltrao DC, de Lima Beltrao FE, et al
     Treatment Preferences in Patients with Hypothyroidism: an Analysis of Eleven Randomized Controlled Trials.
     J Clin Endocrinol Metab. 2024 Sep 18:dgae651. doi: 10.1210.
     PubMed     Abstract available
     
     
     
114. FENG J, Xu X, Cai W, Yang X, et al
     Inhibiting Soluble Epoxide Hydrolase Suppresses NF-kappaB p65 Signaling and Reduces CXCL10 Expression as a Potential Therapeutic Target in Hashimoto's Thyroiditis.
     J Clin Endocrinol Metab. 2024;109:2579-2588.
     PubMed     Abstract available
     
     
     
115. REICH T, Bakirov R, Budka D, Kelly D, et al
     Data-Driven Strategies for Carbimazole Titration: Exploring Machine Learning Solutions in Hyperthyroidism Control.
     J Clin Endocrinol Metab. 2024 Sep 13:dgae642. doi: 10.1210.
     PubMed     Abstract available
     
     
     
116. XU L, Liu Z, Xu X, Wan Q, et al
     Thyroid autoimmunity is associated with dietary fat consumption.
     J Clin Endocrinol Metab. 2024 Sep 12:dgae629. doi: 10.1210.
     PubMed     Abstract available
     
     
     
117. SPONA DC, Frodi DM, Xing LY, Kongebro EK, et al
     Effects of atrial fibrillation screening according to thyroid function: Post-hoc analysis of the randomized LOOP study.
     J Clin Endocrinol Metab. 2024 Sep 4:dgae610. doi: 10.1210.
     PubMed     Abstract available
     
     
     
118. YAN Y, Chu X, Wang J, Kang X, et al
     Alterations in Thyroid Hormones in Obese Patients are Associated with Body Composition Changes after Bariatric Surgery.
     J Clin Endocrinol Metab. 2024 Sep 2:dgae605. doi: 10.1210.
     PubMed     Abstract available
     
     
     August 2024
119. YUAN J, Chen Z, Zhang J, Chen X, et al
     Preoperative Serum Lipids as Novel Predictors of Survival in 3575 Papillary Thyroid Cancer Patients.
     J Clin Endocrinol Metab. 2024 Aug 30:dgae601. doi: 10.1210.
     PubMed     Abstract available
     
     
     
120. MOOIJ CF, Zwaveling-Soonawala N, Hillebrand JJ, van Trotsenburg ASP, et al
     Approach to the Patient: Challenging Cases of Pediatric Thyrotoxicosis.
     J Clin Endocrinol Metab. 2024 Aug 27:dgae592. doi: 10.1210.
     PubMed     Abstract available
     
     
     
121. XU Y, Gao J, Wang N, Zedenius J, et al
     BRAF-induced EHF expression affects TERT in aggressive papillary thyroid cancer.
     J Clin Endocrinol Metab. 2024 Aug 24:dgae589. doi: 10.1210.
     PubMed     Abstract available
     
     
     
122. RAMONE T, Ghirri A, Prete A, Matrone A, et al
     Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance.
     J Clin Endocrinol Metab. 2024 Aug 24:dgae575. doi: 10.1210.
     PubMed     Abstract available
     
     
     
123. STEGENGA MT, Oudijk L, van Velsen EFS, Peeters RP, et al
     Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification.
     J Clin Endocrinol Metab. 2024 Aug 21:dgae581. doi: 10.1210.
     PubMed     Abstract available
     
     
     
124. CASTELLANOS LE, Zafereo ME, Sturgis EM, Wang JR, et al
     Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine.
     J Clin Endocrinol Metab. 2024 Aug 20:dgae576. doi: 10.1210.
     PubMed     Abstract available
     
     
     
125. GRANI G, D'Elia S, Puxeddu E, Morelli S, et al
     Data-Driven Thyroglobulin Cutoffs for Low- and Intermediate-Risk Thyroid Cancer Follow-Up: ITCO Real-World Analysis.
     J Clin Endocrinol Metab. 2024 Aug 16:dgae559. doi: 10.1210.
     PubMed     Abstract available
     
     
     
126. SMITH TJ, Holt RJ, Fu Q, Qashqai A, et al
     Assessment of hearing dysfunction in patients with Graves' disease and thyroid eye disease without or with teprotumumab.
     J Clin Endocrinol Metab. 2024 Aug 14:dgae560. doi: 10.1210.
     PubMed     Abstract available
     
     
     
127. IYER PC, Dadu R, Barque A, Zanelli C, et al
     Analytical Validation of a Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay.
     J Clin Endocrinol Metab. 2024;109:2269-2273.
     PubMed     Abstract available
     
     
     
128. LI G, Ye Z, Wei T, Zhu J, et al
     Clinical Outcomes and Implications of Radioactive Iodine Therapy on Cancer-specific Survival in WHO Classification of FTC.
     J Clin Endocrinol Metab. 2024;109:2294-2305.
     PubMed     Abstract available
     
     
     
129. ENDO M, Peng J, Nabhan FA, Brock P, et al
     Indolent Behavior of Malignant Bethesda III Nodules Compared to Bethesda V/VI Nodules.
     J Clin Endocrinol Metab. 2024;109:2317-2324.
     PubMed     Abstract available
     
     
     
130. KONDA B, Sherman EJ, Massarelli E, Nieva J, et al
     Cabozantinib plus ipilimumab/nivolumab in patients with previously treated advanced differentiated thyroid cancer.
     J Clin Endocrinol Metab. 2024 Aug 12:dgae512. doi: 10.1210.
     PubMed     Abstract available
     
     
     
131. REINKE R, Udholm S, Christiansen CF, Almquist M, et al
     Increased risk of chronic kidney disease after total thyroidectomy: A nationwide matched cohort study.
     J Clin Endocrinol Metab. 2024 Aug 10:dgae534. doi: 10.1210.
     PubMed     Abstract available
     
     
     
132. DUNTAS LH, Zarkovic M
     A small opening in the storm clouds: overview of the registry-based study on the management of thyroid storm.
     J Clin Endocrinol Metab. 2024 Aug 9:dgae543. doi: 10.1210.
     PubMed     Abstract available
     
     
     
133. GHOSH R, Auh S, Gubbi S, Veeraraghavan P, et al
     Association of Free Thyroxine with Progression-Free Survival in Intermediate and High Risk Differentiated Thyroid Cancer.
     J Clin Endocrinol Metab. 2024 Aug 8:dgae537. doi: 10.1210.
     PubMed     Abstract available
     
     
     
134. WANG JR, Zafereo ME, Cabanillas ME, Wu CC, et al
     The association between thyroid differentiation score and survival outcomes in papillary thyroid carcinoma.
     J Clin Endocrinol Metab. 2024 Aug 1:dgae532. doi: 10.1210.
     PubMed     Abstract available
     
     
     July 2024
135. OSINGA JAJ, Nelson SM, Walsh JP, Ashoor G, et al
     Defining gestational thyroid dysfunction through modified non-pregnancy reference intervals: an individual participant meta-analysis.
     J Clin Endocrinol Metab. 2024 Jul 31:dgae528. doi: 10.1210.
     PubMed     Abstract available
     
     
     
136. ALVES JUNIOR JM, Bernardo W, Villagelin D
     "Effectiveness of Different Treatment Modalities in Initial and Chronic Phases of Thyroid Eye Disease: A Systematic Review with Meta-analysis".
     J Clin Endocrinol Metab. 2024 Jul 30:dgae526. doi: 10.1210.
     PubMed     Abstract available
     
     
     
137. SINKO R, Katko M, Toth G, Kovacs GL, et al
     Novel biomarkers reveal mismatch between tissue and serum thyroid hormone status in amiodarone-induced hyperthyroidism.
     J Clin Endocrinol Metab. 2024 Jul 30:dgae514. doi: 10.1210.
     PubMed     Abstract available
     
     
     
138. FENG J, Wu C, Shen F, Cai W, et al
     Second Primary Differentiated Thyroid Carcinoma in Adult Cancer Survivors: A SEER Database Analysis.
     J Clin Endocrinol Metab. 2024 Jul 24:dgae501. doi: 10.1210.
     PubMed     Abstract available
     
     
     
139. LUPO MA, Olivo PD, Luffy M, Wolf J, et al
     US-based, Prospective, Blinded Study of Thyrotropin Receptor Antibody in Autoimmune Thyroid Disease.
     J Clin Endocrinol Metab. 2024 Jul 19:dgae448. doi: 10.1210.
     PubMed     Abstract available
     
     
     
140. GERMAN A, Almashanu S, de Vries L, Gil Margolis M, et al
     Insights into Central Congenital Hypothyroidism: A Multicenter Retrospective Analysis.
     J Clin Endocrinol Metab. 2024 Jul 15:dgae485. doi: 10.1210.
     PubMed     Abstract available
     
     
     
141. ZHOU J, Chen W, Jiang WH, Wu Q, et al
     Altered Static and Dynamic Brain Functional Topological Organization in Patients With Dysthyroid Optic Neuropathy.
     J Clin Endocrinol Metab. 2024;109:2071-2082.
     PubMed     Abstract available
     
     
     
142. JONSDOTTIR B, Clasen JL, Vehik K, Lernmark A, et al
     Early appearance of thyroid autoimmunity in children followed from birth for type 1 diabetes risk.
     J Clin Endocrinol Metab. 2024 Jul 12:dgae478. doi: 10.1210.
     PubMed     Abstract available
     
     
     
143. XIE P, Shen L, Peng R, Wang Y, et al
     Effects of low-dose methotrexate with MMI in patients with Graves' disease: results of a randomized clinical trial.
     J Clin Endocrinol Metab. 2024 Jul 12:dgae472. doi: 10.1210.
     PubMed     Abstract available
     
     
     
144. PIGNATA L, Bagattini B, Di Cosmo C, Agretti P, et al
     Clinical course of congenital hypothyroidism with gland in situ and necessity of L-thyroxine therapy after re-evaluation.
     J Clin Endocrinol Metab. 2024 Jul 10:dgae471. doi: 10.1210.
     PubMed     Abstract available
     
     
     
145. AHMADI S, Sipos JA
     Cost-effectiveness of molecular testing for thyroid nodules with indeterminate cytology.
     J Clin Endocrinol Metab. 2024 Jul 10:dgae470. doi: 10.1210.
     PubMed    
     
     
     
146. WANG H, Li Q, Tian T, Liu B, et al
     Improving the Risk Prediction of the 2015 ATA Recurrence Risk Stratification in Papillary Thyroid Cancer.
     J Clin Endocrinol Metab. 2024 Jul 9:dgae465. doi: 10.1210.
     PubMed     Abstract available
     
     
     
147. AZIZI F, Mehran L, Abdi H, Amouzegar A, et al
     Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves' Disease.
     J Clin Endocrinol Metab. 2024 Jul 9:dgae456. doi: 10.1210.
     PubMed     Abstract available
     
     
     
148. ROVET JF
     Targeting the Manifestations of Subclinical and Overt Hypothyroidism Within the Hippocampus.
     J Clin Endocrinol Metab. 2024 Jul 6:dgae453. doi: 10.1210.
     PubMed     Abstract available
     
     
     
149. JING R, Wu N, Wu Y, Zhang Q, et al
     Efficacy and safety of multikinase inhibitors for patients with refractory thyroid cancer: Systematic review and network meta-analysis.
     J Clin Endocrinol Metab. 2024 Jul 6:dgae454. doi: 10.1210.
     PubMed     Abstract available
     
     
     
150. ZHAI X, Li Y, Teng X, Teng W, et al
     Relationship Between Serum Thyrotropin Levels and Metabolic Diseases in Older Adults.
     J Clin Endocrinol Metab. 2024 Jul 2:dgae387. doi: 10.1210.
     PubMed     Abstract available
     
     
     
151. 
     Correction to: "TERT Promoter Mutations Increase Tumor Aggressiveness by Altering TERT mRNA Splicing in Papillary Thyroid Carcinoma".
     J Clin Endocrinol Metab. 2024 Jul 1:dgae442. doi: 10.1210.
     PubMed    
     
     
     June 2024
152. SEHGAL K, Serritella A, Liu M, ONeill A, et al
     A phase I/II trial of sapanisertib in advanced anaplastic and radioiodine refractory differentiated thyroid carcinoma.
     J Clin Endocrinol Metab. 2024 Jun 29:dgae443. doi: 10.1210.
     PubMed     Abstract available
     
     
     
153. PARDI E, Poma AM, Torregrossa L, Pierotti L, et al
     Whole-exome sequencing of atypical parathyroid tumors detects novel and common genes linked to parathyroid tumorigenesis.
     J Clin Endocrinol Metab. 2024 Jun 28:dgae441. doi: 10.1210.
     PubMed     Abstract available
     
     
     
154. WILLIAMS MD, Liu Z, Rossi ED, Agarwal S, et al
     Seven years of Non-invasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Rate of Acceptance and Variation of Diagnostic Approaches Across Different Continents.
     J Clin Endocrinol Metab. 2024 Jun 14:dgae354. doi: 10.1210.
     PubMed     Abstract available
     
     
     May 2024
155. CAO H, Shangguan L, Zhu H, Hu C, et al
     Prognostic analysis of 131I efficacy after papillary thyroid carcinoma surgery based on CT radiomics.
     J Clin Endocrinol Metab. 2024 May 27:dgae364. doi: 10.1210.
     PubMed     Abstract available
     
     
     
156. MOLLEHAVE LT, Grand MK, Kriegbaum M, Andersen CL, et al
     Maternal thyroid function in early pregnancy and offspring school performance and neurodevelopmental disorders.
     J Clin Endocrinol Metab. 2024 May 24:dgae358. doi: 10.1210.
     PubMed     Abstract available
     
     
     
157. SCHREINER F, Vollbach H, Sonntag N, Schempp V, et al
     Phenylbutyrate Treatment in a Boy with MCT8 Deficiency: Improvement of Thyroid Function Tests and Possible Livertoxicity.
     J Clin Endocrinol Metab. 2024 May 24:dgae356. doi: 10.1210.
     PubMed     Abstract available
     
     
     
158. ETTLESON MD, Penna GCE, Wan W, Bensenor IM, et al
     TSH Trajectories During Levothyroxine Treatment in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) Cohort.
     J Clin Endocrinol Metab. 2024 May 23:dgae294. doi: 10.1210.
     PubMed     Abstract available
     
     
     
159. LEVESQUE F, Payne RJ, Beaudoin D, Boucher A, et al
     A Prospective Study of Publicly Funded Molecular Testing of Indeterminate Thyroid Nodules: Canada's Experience.
     J Clin Endocrinol Metab. 2024 May 23:dgae355. doi: 10.1210.
     PubMed     Abstract available
     
     
     
160. GRANI G
     The pathologist counts-so many variables in the risk stratification of thyroid cancers.
     J Clin Endocrinol Metab. 2024 May 22:dgae360. doi: 10.1210.
     PubMed    
     
     
     
161. LI G, Chen W, Jiang K, Huang J, et al
     Exosome-mediated Delivery of miR-519e-5p Promotes Malignant Tumor Phenotype and CD8+ T-Cell Exhaustion in Metastatic PTC.
     J Clin Endocrinol Metab. 2024;109:1601-1617.
     PubMed     Abstract available
     
     
     
162. CONOVER CA, Bale LK, Stan MN
     PAPP-A as a Potential Target in Thyroid Eye Disease.
     J Clin Endocrinol Metab. 2024 May 16:dgae339. doi: 10.1210.
     PubMed     Abstract available
     
     
     
163. XIAN K, Xu S, Huang H, Xing C, et al
     Synergy of nodal factors in predicting recurrence after treatment of N1b papillary thyroid carcinoma.
     J Clin Endocrinol Metab. 2024 May 15:dgae329. doi: 10.1210.
     PubMed     Abstract available
     
     
     
164. SCHOLZ A, McNabb CB, Bloomfield L, Bhargava R, et al
     Controlled Antenatal Thyroid Screening Study III: Effects of gestational thyroid status on adolescent brain morphology.
     J Clin Endocrinol Metab. 2024 May 15:dgae338. doi: 10.1210.
     PubMed     Abstract available
     
     
     
165. ZHANG W, Lin S, Wang Z, Zhang W, et al
     Coexisting RET/PTC and TERT Promoter Mutation Predict Poor Prognosis but Effective RET and MEK Targets in Thyroid Cancer.
     J Clin Endocrinol Metab. 2024 May 13:dgae327. doi: 10.1210.
     PubMed     Abstract available
     
     
     
166. SOHN SY, Inoue K, Bashir MT, Currier JW, et al
     Thyroid Dysfunction Risk After Iodinated Contrast Media Administration: A Prospective Longitudinal Cohort Analysis.
     J Clin Endocrinol Metab. 2024 May 3:dgae304. doi: 10.1210.
     PubMed     Abstract available
     
     
     April 2024
167. PETROVIC I, LoPresti J, Fatemi S, Gianoukakis A, et al
     Influence of Thyroglobulin (Tg) Autoantibodies on Tg levels Measured by Different Methodologies: (IMA, LC-MS/MS and RIA).
     J Clin Endocrinol Metab. 2024 Apr 30:dgae286. doi: 10.1210.
     PubMed     Abstract available
     
     
     
168. SANT VR, Radhachandran A, Ivezic V, Lee DT, et al
     From Bench-to-Bedside: How Artificial Intelligence Is Changing Thyroid Nodule Diagnostics.
     J Clin Endocrinol Metab. 2024 Apr 29:dgae277. doi: 10.1210.
     PubMed     Abstract available
     
     
     
169. SUN F, Zhang RJ, Fang Y, Yan CY, et al
     Identification of Eukaryotic Translation Initiation Factor 4B as a Novel Candidate Gene for Congenital Hypothyroidism.
     J Clin Endocrinol Metab. 2024 Apr 24:dgae270. doi: 10.1210.
     PubMed     Abstract available
     
     
     
170. ABOU AZAR S, Tobias J, Applewhite M, Angelos P, et al
     Medullary Thyroid Cancer: Single Institute Experience over Three Decades and Risk Factors for Recurrence.
     J Clin Endocrinol Metab. 2024 Apr 23:dgae279. doi: 10.1210.
     PubMed     Abstract available
     
     
     
171. CHO YY, Ahn SH, Lee EK, Park YJ, et al
     Malignancy Risk of Follicular Neoplasm (Bethesda IV) With Variable Cutoffs of Tumor Size: A Systemic Review and Meta-Analysis.
     J Clin Endocrinol Metab. 2024;109:1383-1392.
     PubMed     Abstract available
     
     
     
172. TODA S, Hiroshima Y, Iwasaki H, Masudo K, et al
     Genomic landscape and clinical features of advanced thyroid carcinoma: a national database study in Japan.
     J Clin Endocrinol Metab. 2024 Apr 17:dgae271. doi: 10.1210.
     PubMed     Abstract available
     
     
     
173. LEE J, Baek HS, Jo K, Kim MH, et al
     The Impact of Physical Activity on Thyroid Health: Insights From Representative Data in Korea.
     J Clin Endocrinol Metab. 2024 Apr 15:dgae178. doi: 10.1210.
     PubMed     Abstract available
     
     
     
174. BAEK HS, Kim J, Jeong C, Lee J, et al
     Deep Learning Analysis with Gray Scale and Doppler Ultrasonography Images to Differentiate Graves' Disease.
     J Clin Endocrinol Metab. 2024 Apr 13:dgae254. doi: 10.1210.
     PubMed     Abstract available
     
     
     
175. GUO S, Li R, Li G, Chen W, et al
     Comparing ChatGPT's and surgeon's responses to thyroid-related questions from patients.
     J Clin Endocrinol Metab. 2024 Apr 10:dgae235. doi: 10.1210.
     PubMed     Abstract available
     
     
     
176. PERROS P, Nagy EV, Papini E, Abad-Madronero J, et al
     Hypothyroidism and Type D Personality: Results From E-MPATHY, a Cross-sectional International Online Patient Survey.
     J Clin Endocrinol Metab. 2024 Apr 9:dgae140. doi: 10.1210.
     PubMed     Abstract available
     
     
     
177. HUANG PS, Tsai CT
     Response to Letter to the Editor From Sukor and Kamaruddin: "Higher Risk of Incident Hyperthyroidism in Patients with Atrial Fibrillation".
     J Clin Endocrinol Metab. 2024 Apr 8:dgae190. doi: 10.1210.
     PubMed    
     
     
     
178. VILLAGELIN D, Cooper DS, Burch HB
     A 2023 International Survey of Clinical Practice Patterns in the Management of Graves' Disease: A Decade of Change.
     J Clin Endocrinol Metab. 2024 Apr 5:dgae222. doi: 10.1210.
     PubMed     Abstract available
     
     
     
179. SAKO A, Matsuse M, Saenko V, Tanaka A, et al
     TERT promoter mutations increase tumor aggressiveness by altering TERT mRNA splicing in papillary thyroid carcinoma.
     J Clin Endocrinol Metab. 2024 Apr 5:dgae220. doi: 10.1210.
     PubMed     Abstract available
     
     
     
180. NEWMAN SK, Tuttle RM
     Redefining actionable disease in well differentiated thyroid cancer management.
     J Clin Endocrinol Metab. 2024 Apr 4:dgae218. doi: 10.1210.
     PubMed    
     
     
     
181. LIU CQ, Shen CK, Du YX, Li ZM, et al
     Survival outcome and optimal candidates of primary tumor resection for patients with metastatic medullary thyroid cancer.
     J Clin Endocrinol Metab. 2024 Apr 4:dgae214. doi: 10.1210.
     PubMed     Abstract available
     
     
     March 2024
182. LEE-SAXTON YJ, Egan CE, Bratton BA, Thiesmeyer JW, et al
     Low Mitotic Activity in Papillary Thyroid Cancer: A Marker for Aggressive Features and Recurrence.
     J Clin Endocrinol Metab. 2024 Mar 30:dgae203. doi: 10.1210.
     PubMed     Abstract available
     
     
     
183. MATSUO Y, Miyawaki A, Watanabe H, Matsui H, et al
     Potassium Iodide Use and Patient Outcomes for Thyroid Storm: An Observational Study.
     J Clin Endocrinol Metab. 2024 Mar 28:dgae187. doi: 10.1210.
     PubMed     Abstract available
     
     
     
184. SUKOR N, Kamaruddin NA
     Letter to the Editor from Sukor and Kamaruddin "Higher Risk of Incident Hyperthyroidism in Patients with Atrial Fibrillation".
     J Clin Endocrinol Metab. 2024 Mar 27:dgae189. doi: 10.1210.
     PubMed    
     
     
     
185. HIRTZ R, Thamm R, Kuhnert R, Liesenkotter KP, et al
     New Reference Values for Thyroid Volume by Ultrasound in German Children and Adolescents from a Population-Based Study.
     J Clin Endocrinol Metab. 2024 Mar 26:dgae194. doi: 10.1210.
     PubMed     Abstract available
     
     
     
186. 
     Correction to: "Structural and Functional Alterations of Hippocampal Subfields in Patients With Adult-Onset Primary Hypothyroidism".
     J Clin Endocrinol Metab. 2024 Mar 20:dgae159. doi: 10.1210.
     PubMed    
     
     
     
187. PENNA GC, Bensenor IM, Bianco AC, Ettleson MD, et al
     Thyroid hormone homeostasis in levothyroxine-treated patients: Findings from ELSA-Brasil.
     J Clin Endocrinol Metab. 2024 Mar 20:dgae139. doi: 10.1210.
     PubMed     Abstract available
     
     
     
188. MAROTTA V, Rocco D, Crocco A, Deiana MG, et al
     Survival predictors of radioiodine-refractory differentiated thyroid cancer treated with lenvatinib in the real-life.
     J Clin Endocrinol Metab. 2024 Mar 19:dgae181. doi: 10.1210.
     PubMed     Abstract available
     
     
     
189. 
     Correction to: "The Cross-sectional and Longitudinal Association Between Thyroid Function and Depression: A Population-Based Study".
     J Clin Endocrinol Metab. 2024 Mar 14:dgae148. doi: 10.1210.
     PubMed    
     
     
     
190. OHIRA T, Nagao M, Hayashi F, Shimura H, et al
     Effects of Overweight on Risk of Thyroid Nodules in Children and Adolescents: The Fukushima Health Management Survey.
     J Clin Endocrinol Metab. 2024 Mar 13:dgae161. doi: 10.1210.
     PubMed     Abstract available
     
     
     
191. FURUKAWA Y, Tanaka K, Isozaki O, Suzuki A, et al
     Prospective Multicenter Registry-Based Study on Thyroid Storm: The Guidelines for the Management from Japan are Useful.
     J Clin Endocrinol Metab. 2024 Mar 8:dgae124. doi: 10.1210.
     PubMed     Abstract available
     
     
     
192. DAYAN CM
     The Race for New Treatments for Graves Orbitopathy (Thyroid Eye Disease).
     J Clin Endocrinol Metab. 2024 Mar 7:dgad693. doi: 10.1210.
     PubMed    
     
     
     
193. CHEN H, Liu Y, Wang F, Sun J, et al
     MeIS: DNA methylation-based immune response signatures for thyroid nodule diagnostics.
     J Clin Endocrinol Metab. 2024 Mar 7:dgae141. doi: 10.1210.
     PubMed     Abstract available
     
     
     
194. HENSLEY SG, Hu MI, Bassett RL, Ying AK, et al
     Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-term Outcomes in 144 Patients Over Six Decades.
     J Clin Endocrinol Metab. 2024 Mar 4:dgae133. doi: 10.1210.
     PubMed     Abstract available
     
     
     February 2024
195. SARKAR R, Bolel P, Kapoor A, Eliseeva E, et al
     An Orally Efficacious Thyrotropin Receptor Ligand Inhibits Growth and Metastatic Activity of Thyroid Cancers.
     J Clin Endocrinol Metab. 2024 Feb 29:dgae114. doi: 10.1210.
     PubMed     Abstract available
     
     
     
196. LACLAUSTRA M, Alonso-Ventura V, Schipf S, Lou-Bonafonte JM, et al
     Higher Parametric Thyroid Feedback Quantile-based Index is a predictor of type 2 diabetes in a German population sample.
     J Clin Endocrinol Metab. 2024 Feb 29:dgae110. doi: 10.1210.
     PubMed     Abstract available
     
     
     
197. JAGANNATH S, Mayilvaganan S
     Letter to the Editor from Jagannath and Mayilvaganan: "Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma".
     J Clin Endocrinol Metab. 2024 Feb 29:dgae117. doi: 10.1210.
     PubMed    
     
     
     
198. SCHOLFIELD DW, Lopez J, Eagan A, Antal Z, et al
     Response to Letter to the Editor from Jagannath and Mayilvaganan: "Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?".
     J Clin Endocrinol Metab. 2024 Feb 28:dgae118. doi: 10.1210.
     PubMed    
     
     
     
199. AHMADI S, Kotwal A, Bikas A, Xiang P, et al
     Outcomes of cytologically indeterminate thyroid nodules managed with Genomic Sequencing Classifier.
     J Clin Endocrinol Metab. 2024 Feb 28:dgae112. doi: 10.1210.
     PubMed     Abstract available
     
     
     
200. VAN DER TUIN K, Ruano D, Knijnenburg J, van der Luijt RB, et al
     Clinically-relevant Germline Variants in Children with Non-Medullary Thyroid Cancer.
     J Clin Endocrinol Metab. 2024 Feb 28:dgae107. doi: 10.1210.
     PubMed     Abstract available
     
     
     
201. MAINO F, Botte M, Dalmiglio C, Valerio L, et al
     Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.
     J Clin Endocrinol Metab. 2024;109:722-729.
     PubMed     Abstract available
     
     
     
202. TANASE-NAKAO K, Iwahashi-Odano M, Sugisawa C, Abe K, et al
     Genotype-Phenotype Correlations in Thirty Japanese Patients with Congenital Hypothyroidism Attributable to TG Defects.
     J Clin Endocrinol Metab. 2024 Feb 19:dgae098. doi: 10.1210.
     PubMed     Abstract available
     
     
     
203. ALTSHULER B, Bikas A, Pappa T, Marqusee E, et al
     Non-Operative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules.
     J Clin Endocrinol Metab. 2024 Feb 13:dgae082. doi: 10.1210.
     PubMed     Abstract available
     
     
     
204. STEGENGA MT, van Velsen EFS, Oudijk L, Verburg FA, et al
     Clinical and Histopathological Risk Factors for Radioactive Iodine Refractory Follicular and Oncocytic Thyroid Carcinoma.
     J Clin Endocrinol Metab. 2024 Feb 13:dgae084. doi: 10.1210.
     PubMed     Abstract available
     
     
     
205. 
     Correction to: "Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination".
     J Clin Endocrinol Metab. 2024 Feb 8:dgae064. doi: 10.1210.
     PubMed    
     
     
     
206. 
     Correction to: "Nodal Metastases Associated With Fusion Oncogenes Are Age Dependent in Young Adult Patients With Thyroid Cancer".
     J Clin Endocrinol Metab. 2024 Feb 7:dgae065. doi: 10.1210.
     PubMed    
     
     
     
207. ZHANG T, Zhao L, Chen C, Yang C, et al
     Structural and Functional Alterations of Hippocampal Subfields in Patients with Adult-onset Primary Hypothyroidism.
     J Clin Endocrinol Metab. 2024 Feb 7:dgae070. doi: 10.1210.
     PubMed     Abstract available
     
     
     January 2024
208. DOSIOU C
     "Teprotumumab for inactive thyroid eye disease? The jury is still out.".
     J Clin Endocrinol Metab. 2024 Jan 27:dgae052. doi: 10.1210.
     PubMed    
     
     
     
209. WANG H, Peng Y, Xia X, Jiang Y, et al
     Effect of thyroid function on offspring neurodevelopment in people receiving ART therapy: a prospective cohort study.
     J Clin Endocrinol Metab. 2024 Jan 24:dgae046. doi: 10.1210.
     PubMed     Abstract available
     
     
     
210. LOPES-PEREIRA M, Roque S, Machado SI, Korevaar TIM, et al
     Iodineminho Study: Iodine Supplementation and Prevalence of Iodine Deficiency in Pregnant Women.
     J Clin Endocrinol Metab. 2024 Jan 24:dgae041. doi: 10.1210.
     PubMed     Abstract available
     
     
     
211. CONDELLO V, Poma AM, Macerola E, Vignali P, et al
     Prevalence, Molecular Landscape and Clinical Impact of DICER1 and DGCR8 Mutated Follicular-Patterned Thyroid Nodules.
     J Clin Endocrinol Metab. 2024 Jan 22:dgae034. doi: 10.1210.
     PubMed     Abstract available
     
     
     
212. DE ANGELIS S, Medda E, Rotondi D, Masocco M, et al
     Fifteen Years of Iodine Prophylaxis in Italy: Results of a Nationwide Surveillance (Period 2015-2019).
     J Clin Endocrinol Metab. 2024;109:e495-e507.
     PubMed     Abstract available
     
     
     
213. JENSEN CZ, Isaksen JL, Ahlberg G, Olesen MS, et al
     Association of DIO2 and MCT10 Polymorphisms With Persistent Symptoms in LT4-Treated Patients in the UK Biobank.
     J Clin Endocrinol Metab. 2024;109:e613-e622.
     PubMed     Abstract available
     
     
     
214. LUDAR H, Levy-Shraga Y, Admoni O, Majdoub H, et al
     Clinical and Molecular Characteristics and Long-term Follow-up of Children With Pseudohypoparathyroidism Type IA.
     J Clin Endocrinol Metab. 2024;109:424-438.
     PubMed     Abstract available
     
     
     
215. BHARADWAJ MS, Ballal S, Bal C
     Optimal Cumulative I-131 Activity in Metastatic Differentiated Thyroid Cancer: Balancing Efficacy and Adverse Events.
     J Clin Endocrinol Metab. 2024 Jan 12:dgae024. doi: 10.1210.
     PubMed     Abstract available
     
     
     
216. BARASCH E, Gottdiener J, Buzkova P, Cappola A, et al
     Association of thyroid dysfunction in individuals >/= 65 years of age with subclinical cardiac abnormalities.
     J Clin Endocrinol Metab. 2024 Jan 6:dgae001. doi: 10.1210.
     PubMed     Abstract available
     
     
     
217. BUCZYNSKA A, Kosciuszko M, Sidorkiewicz I, Wiatr AA, et al
     Enhancing Angioinvasion Assessment in Papillary Thyroid Cancer via a Biomarker Panel Involving TAC, 8-OHdG and Sortilin.
     J Clin Endocrinol Metab. 2024 Jan 5:dgae007. doi: 10.1210.
     PubMed     Abstract available
     
     
     
218. 
     Correction to: "Ectopic Cervical Thymoma in a Patient Diagnosed With Graves Disease: A Systematic Literature Review".
     J Clin Endocrinol Metab. 2024 Jan 3:dgad759. doi: 10.1210.
     PubMed    
     
     
     December 2023
219. KIM BH, Ryu SR, Lee JW, Song CM, et al
     Longitudinal changes in quality of life before and after thyroidectomy in patients with differentiated thyroid cancer.
     J Clin Endocrinol Metab. 2023 Dec 23:dgad748. doi: 10.1210.
     PubMed     Abstract available
     
     
     
220. WEN X, Chang X, He X, Cai Q, et al
     Increased Thyroid DPP4 Expression is Associated with Inflammatory Process in Patients with Hashimoto's Thyroiditis.
     J Clin Endocrinol Metab. 2023 Dec 21:dgad723. doi: 10.1210.
     PubMed     Abstract available
     
     
     
221. PAPARODIS R, Livadas S, Karvounis E, Bantouna D, et al
     Elevated Preoperative TPO Ab Titers Decrease Risk for DTC in a Linear Fashion: A Retrospective Analysis of 1635 Cases.
     J Clin Endocrinol Metab. 2023;109:e347-e355.
     PubMed     Abstract available
     
     
     
222. GOLDNER W
     The Role of Age in the Risk Assessment of Differentiated Thyroid Cancers.
     J Clin Endocrinol Metab. 2023 Dec 20:dgad743. doi: 10.1210.
     PubMed    
     
     
     
223. DING X, Liu Z, Zhang B, Yang Y, et al
     Permanent versus Transient Congenital Hypothyroidism in Chinese Children: Physical Growth and Predictive Nomogram.
     J Clin Endocrinol Metab. 2023 Dec 16:dgad739. doi: 10.1210.
     PubMed     Abstract available
     
     
     
224. QIN Z, Muhanhali D, Ling Y
     Impaired thyroid hormone sensitivity increases risk of cardiovascular events in patients undergoing coronary angiography.
     J Clin Endocrinol Metab. 2023 Dec 16:dgad735. doi: 10.1210.
     PubMed     Abstract available
     
     
     
225. LIN S, Wang Z, Xing M
     Association between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality.
     J Clin Endocrinol Metab. 2023 Dec 8:dgad722. doi: 10.1210.
     PubMed     Abstract available
     
     
     
226. MU Z, Zhang X, Sun D, Sun Y, et al
     Characterizing genetic alterations related to radioiodine avidity in metastatic thyroid cancer.
     J Clin Endocrinol Metab. 2023 Dec 7:dgad697. doi: 10.1210.
     PubMed     Abstract available
     
     
     
227. CHEN DW, Singh Ospina N, Haymart MR
     Social Determinants of Health and Disparities in Thyroid Care.
     J Clin Endocrinol Metab. 2023 Dec 6:dgad716. doi: 10.1210.
     PubMed     Abstract available
     
     
     
228. LEUNG AM, Brent GA
     Pregnancy - Does Promotion of Growth Extend to Thyroid Cancer?
     J Clin Endocrinol Metab. 2023 Dec 2:dgad707. doi: 10.1210.
     PubMed    
     
     
     
229. WANG Y, Zou B, Zhang Y, Zhang J, et al
     Comprehensive long-read sequencing analysis discloses the transcriptome features of Papillary Thyroid Microcarcinoma.
     J Clin Endocrinol Metab. 2023 Dec 1:dgad695. doi: 10.1210.
     PubMed     Abstract available
     
     
     November 2023
230. YAMAZAKI H, Sugino K, Katoh R, Matsuzu K, et al
     Role of the degree of vascular invasion in predicting prognosis of follicular thyroid carcinoma.
     J Clin Endocrinol Metab. 2023 Nov 25:dgad689. doi: 10.1210.
     PubMed     Abstract available
     
     
     
231. 
     Correction to: "Critical Approach to Hypothyroid Patients With Persistent Symptoms".
     J Clin Endocrinol Metab. 2023 Nov 23:dgad678. doi: 10.1210.
     PubMed    
     
     
     
232. MORAN C, Schoenmakers N, Halsall D, Oddy S, et al
     Approach to the patient with raised thyroid hormones and non-suppressed TSH.
     J Clin Endocrinol Metab. 2023 Nov 21:dgad681. doi: 10.1210.
     PubMed     Abstract available
     
     
     
233. LIU Q, Mao L, Zhang Z, Li G, et al
     Diagnostic Efficacy of FNA-Tg in DTC Cervical LN Metastasis and its Impact Factors: A Large Retrospective Study.
     J Clin Endocrinol Metab. 2023;108:3311-3319.
     PubMed     Abstract available
     
     
     
234. STRICH D, Israel A, Edri S, Gillis D, et al
     Age and Gender Adjusted FT3 Levels as Novel Predictors of Survival.
     J Clin Endocrinol Metab. 2023;108:3295-3301.
     PubMed     Abstract available
     
     
     
235. LI P, Liu Y, Wei T, Wang X, et al
     Effect and interactions of BRAF on lymph node metastasis in papillary thyroid carcinoma with Hashimoto's thyroiditis.
     J Clin Endocrinol Metab. 2023 Nov 15:dgad667. doi: 10.1210.
     PubMed     Abstract available
     
     
     
236. LAFONTAINE N, Shore CJ, Campbell PJ, Mullin BH, et al
     Epigenome-wide association study shows differential DNA methylation of MDC1, KLF9 and CUTA in autoimmune thyroid disease.
     J Clin Endocrinol Metab. 2023 Nov 14:dgad659. doi: 10.1210.
     PubMed     Abstract available
     
     
     October 2023
237. KWON H, Han KD, Moon SJ, Park SE, et al
     Nonalcoholic Fatty Liver Disease and the Risk of Thyroid Cancer Among Young Adults in South Korea.
     J Clin Endocrinol Metab. 2023 Oct 31:dgad575. doi: 10.1210.
     PubMed     Abstract available
     
     
     
238. DOUGLAS RS, Couch S, Wester ST, Fowler BT, et al
     Efficacy and Safety of Teprotumumab in Thyroid Eye Disease Patients with Long Duration and Low Disease Activity.
     J Clin Endocrinol Metab. 2023 Oct 31:dgad637. doi: 10.1210.
     PubMed     Abstract available
     
     
     
239. NEMIROFF S, Chai R, Fan J, Ramer-Bass I, et al
     Ectopic Cervical Thymoma in a Patient Diagnosed with Graves Disease: A Systematic Literature Review.
     J Clin Endocrinol Metab. 2023 Oct 28:dgad635. doi: 10.1210.
     PubMed     Abstract available
     
     
     
240. MORRIS EJ, Vouri SM, Maraka S, Singh Ospina N, et al
     Trends and components of thyroid status evaluation in commercially insured adults in the US, 2006-2020.
     J Clin Endocrinol Metab. 2023 Oct 27:dgad632. doi: 10.1210.
     PubMed     Abstract available
     
     
     
241. PENNA GC, Bianco AC, Ettleson MD
     A cross-sectional analysis of cardiovascular and bone healthcare utilization during treatment with thyroid hormone.
     J Clin Endocrinol Metab. 2023 Oct 25:dgad629. doi: 10.1210.
     PubMed     Abstract available
     
     
     
242. WU Q, Zhou J, Fang W, Jiang WH, et al
     Structural and functional brain changes after glucocorticoid therapy in thyroid-associated ophthalmopathy.
     J Clin Endocrinol Metab. 2023 Oct 21:dgad626. doi: 10.1210.
     PubMed     Abstract available
     
     
     
243. VAN DER SPOEL E, van Vliet NA, Poortvliet RKE, Du Puy RS, et al
     Incidence and determinants of spontaneous normalization of subclinical hypothyroidism in older adults.
     J Clin Endocrinol Metab. 2023 Oct 20:dgad623. doi: 10.1210.
     PubMed     Abstract available
     
     
     
244. ROA DUENAS OH, Hofman A, Luik AI, Medici M, et al
     The Cross-sectional and Longitudinal Association Between Thyroid Function and Depression: A Population-Based Study.
     J Clin Endocrinol Metab. 2023 Oct 19:dgad620. doi: 10.1210.
     PubMed     Abstract available
     
     
     
245. LUI DTW, Wong CKH, Man KKC
     Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
     J Clin Endocrinol Metab. 2023 Oct 17:dgad614. doi: 10.1210.
     PubMed    
     
     
     
246. MULLER I, Consonni D, Crivicich E, di Marco F, et al
     Response to Letter to the Editor from Lui et al: 'Increased risk of Thyroid Eye Disease following Covid-19 Vaccination'.
     J Clin Endocrinol Metab. 2023 Oct 17:dgad616. doi: 10.1210.
     PubMed    
     
     
     
247. LI Y, Sun J, Jiao Y, Li N, et al
     Impaired sensitivity to thyroid hormones is associated with decreased vitamin D levels in the euthyroid population.
     J Clin Endocrinol Metab. 2023 Oct 13:dgad607. doi: 10.1210.
     PubMed     Abstract available
     
     
     
248. 
     Correction to "Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study".
     J Clin Endocrinol Metab. 2023 Oct 11:dgad596. doi: 10.1210.
     PubMed    
     
     
     
249. GORSHTEIN A, Turjeman A, Duskin-Bitan H, Leibovici L, et al
     Graves' disease following COVID-19 vaccination: a population-based, matched case-control study.
     J Clin Endocrinol Metab. 2023 Oct 10:dgad582. doi: 10.1210.
     PubMed     Abstract available
     
     
     
250. DAI P, Zhao W, Zheng X, Luo H, et al
     Effect of radioactive iodine therapy on cancer-specific survival of papillary thyroid cancer tall cell variant.
     J Clin Endocrinol Metab. 2023 Oct 7:dgad580. doi: 10.1210.
     PubMed     Abstract available
     
     
     
251. ESFANDIARI NH, Papaleontiou M
     Levothyroxine Prescribing: Why Simple is so Complex.
     J Clin Endocrinol Metab. 2023 Oct 4:dgad585. doi: 10.1210.
     PubMed    
     
     
     
252. ZHANG S, Zhao X, Wang X, Jin H, et al
     Gut microecology may be involved in pathogenesis of Hashimoto's thyroiditis by reducing production of hydrogen sulfide.
     J Clin Endocrinol Metab. 2023 Oct 4:dgad588. doi: 10.1210.
     PubMed     Abstract available
     
     
     
253. 
     Correction to "The Outcomes of First Reoperation for Locoregionally Recurrent/Persistent Papillary Thyroid Carcinoma in Patients Who Initially Underwent Total Thyroidectomy and Remnant Ablation".
     J Clin Endocrinol Metab. 2023 Oct 3:dgad573. doi: 10.1210.
     PubMed    
     
     
     September 2023
254. PALYGA I, Rumian M, Kosel A, Albrzykowski M, et al
     The frequency of differentiated thyroid cancer recurrence in 2302 patients with excellent response to primary therapy.
     J Clin Endocrinol Metab. 2023 Sep 28:dgad571. doi: 10.1210.
     PubMed     Abstract available
     
     
     
255. NAESSEN S, Eliasson M, Berntorp K, Kitlinski M, et al
     Autoimmune disease in Turner syndrome in Sweden: An up to 25 years controlled follow-up study.
     J Clin Endocrinol Metab. 2023 Sep 27:dgad566. doi: 10.1210.
     PubMed     Abstract available
     
     
     
256. MELING STOKLAND AE, Austdal M, Nedrebo BG, Carlsen S, et al
     Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy.
     J Clin Endocrinol Metab. 2023 Sep 25:dgad538. doi: 10.1210.
     PubMed     Abstract available
     
     
     
257. OSINGA JAJ, Derakhshan A, Feldt-Rasmussen U, Huang K, et al
     TSH and FT4 reference interval recommendations and prevalence of gestational thyroid dysfunction: quantification of current diagnostic approaches.
     J Clin Endocrinol Metab. 2023 Sep 22:dgad564. doi: 10.1210.
     PubMed     Abstract available
     
     
     
258. XIAO WC, Li X, Shan R, Mei F, et al
     Pregnancy and progression of differentiated thyroid cancer: A propensity score-matched retrospective cohort study.
     J Clin Endocrinol Metab. 2023 Sep 20:dgad557. doi: 10.1210.
     PubMed     Abstract available
     
     
     
259. ZHANG X, Wang Y, Wang H, Zhang X, et al
     Trends in Prevalence of Thyroid Dysfunction and its Associations with Mortality Among US Participants, 1988-2012.
     J Clin Endocrinol Metab. 2023 Sep 20:dgad558. doi: 10.1210.
     PubMed     Abstract available
     
     
     
260. WANG M, Jiang X, Geng J, Hui S, et al
     Outcomes of Patients With Dysthyroid Optic Neuropathy Treated With Intravenous Corticosteroids and/or Orbital Decompression Surgery: A Systematic Review and Meta-analysis.
     J Clin Endocrinol Metab. 2023;108:2717-2727.
     PubMed     Abstract available
     
     
     
261. DE MORAIS NS, Leung AM
     Maternal Thyroid Function: Does it Have a Role in Fetal Programming and Later Offspring Growth?
     J Clin Endocrinol Metab. 2023 Sep 14:dgad552. doi: 10.1210.
     PubMed    
     
     
     
262. UELAND GA, Ueland HO, Stokland AM, Bhan A, et al
     Prevalence, risk factors, clinical and biochemical characteristics of Alemtuzumab-induced Graves' disease.
     J Clin Endocrinol Metab. 2023 Sep 14:dgad540. doi: 10.1210.
     PubMed     Abstract available
     
     
     
263. MENEGHINI V, Tebar WR, Santos IS, Janovsky CCPS, et al
     Potential determinants of thyroid peroxidase antibodies and mortality risk: results from the ELSA-Brasil study.
     J Clin Endocrinol Metab. 2023 Sep 12:dgad539. doi: 10.1210.
     PubMed     Abstract available
     
     
     
264. POZDEYEV N, Dighe M, Barrio M, Raeburn C, et al
     Thyroid cancer polygenic risk score improves classification of thyroid nodules as benign or malignant.
     J Clin Endocrinol Metab. 2023 Sep 8:dgad530. doi: 10.1210.
     PubMed     Abstract available
     
     
     
265. RAMZY A, Saber N, Bruin JE, Thompson DM, et al
     Thyroid hormone levels correlate with the maturation of implanted pancreatic endoderm cells in patients with type 1 diabetes.
     J Clin Endocrinol Metab. 2023 Sep 6:dgad499. doi: 10.1210.
     PubMed     Abstract available
     
     
     
266. AYALA IN, Soto Jacome C, Toro-Tobon D, Golembiewski E, et al
     Appropriateness of Levothyroxine Prescription: A Multicenter Retrospective Study.
     J Clin Endocrinol Metab. 2023 Sep 1:dgad517. doi: 10.1210.
     PubMed     Abstract available
     
     
     August 2023
267. FU J, Guan H
     The Impact of Salt Iodization on the Occurrence of Hyperthyroidism: Evidence from General Populations to Pregnant Women.
     J Clin Endocrinol Metab. 2023 Aug 31:dgad522. doi: 10.1210.
     PubMed    
     
     
     
268. HUANG K, Su S, Wang X, Hu M, et al
     Association between maternal thyroid function in early pregnancy and gestational diabetes: a prospective cohort study.
     J Clin Endocrinol Metab. 2023 Aug 30:dgad518. doi: 10.1210.
     PubMed     Abstract available
     
     
     
269. GILLIS A, Chen H, Wang TS, Dream S, et al
     Racial and Ethnic Disparities in the Diagnosis and Treatment of Thyroid Disease: a Mini- Review.
     J Clin Endocrinol Metab. 2023 Aug 30:dgad519. doi: 10.1210.
     PubMed     Abstract available
     
     
     
270. MULLER I, Consonni D, Crivicich E, Di Marco F, et al
     Increased risk of Thyroid Eye Disease following Covid-19 Vaccination.
     J Clin Endocrinol Metab. 2023 Aug 25:dgad501. doi: 10.1210.
     PubMed     Abstract available
     
     
     
271. JU G, Sun Y, Wang H, Zhang X, et al
     Fusion oncogenes in patients with locally advanced or distant metastatic differentiated thyroid cancer.
     J Clin Endocrinol Metab. 2023 Aug 25:dgad500. doi: 10.1210.
     PubMed     Abstract available
     
     
     
272. HA EJ, Lee JH, Lee DH, Moon J, et al
     Artificial Intelligence Model Assisting Thyroid Nodule Diagnosis and Management: A Multicenter Diagnostic Study.
     J Clin Endocrinol Metab. 2023 Aug 25:dgad503. doi: 10.1210.
     PubMed     Abstract available
     
     
     
273. HARAGUCHI T, Hamamoto Y, Kuwata H, Yamazaki Y, et al
     Effect of Roxadustat on Thyroid Function in Patients with Renal Anemia.
     J Clin Endocrinol Metab. 2023 Aug 19:dgad483. doi: 10.1210.
     PubMed     Abstract available
     
     
     
274. STAN MN, Krieger CC
     The Adverse Effects Profile of Teprotumumab.
     J Clin Endocrinol Metab. 2023;108:e654-e662.
     PubMed     Abstract available
     
     
     
275. MACHENS A, Lorenz K, Brandenburg T, Fuhrer-Sakel D, et al
     The Changing Face of Multiple Endocrine Neoplasia 2A: From Symptom-Based to Preventative Medicine.
     J Clin Endocrinol Metab. 2023;108:e734-e742.
     PubMed     Abstract available
     
     
     
276. LI Z, Luo Y, Huang Q, Chen Z, et al
     A randomized clinical trial of intravenous methylprednisolone with two protocols in patients with Graves' Orbitopathy.
     J Clin Endocrinol Metab. 2023 Aug 14:dgad476. doi: 10.1210.
     PubMed     Abstract available
     
     
     
277. HUANG PS, Cheng JF, Chen JJ, Wang YC, et al
     Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation.
     J Clin Endocrinol Metab. 2023 Aug 11:dgad448. doi: 10.1210.
     PubMed     Abstract available
     
     
     
278. AGBAHT K, Sahin M
     Response to Letter to the Editor from Kleebayoon and Wiuwanikit: 'Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study'.
     J Clin Endocrinol Metab. 2023 Aug 9:dgad462. doi: 10.1210.
     PubMed    
     
     
     
279. LI H, Han R, Meng L, Sun Y, et al
     Nodal Metastases Associated with Fusion Oncogenes Are Age Dependent in Young Adult Patients with Thyroid Cancer.
     J Clin Endocrinol Metab. 2023 Aug 3:dgad458. doi: 10.1210.
     PubMed     Abstract available
     
     
     July 2023
280. HAN S, Jeong S, Choi S, Park SJ, et al
     Association of thyroid hormone medication adherence with risk of dementia.
     J Clin Endocrinol Metab. 2023 Jul 29:dgad447. doi: 10.1210.
     PubMed     Abstract available
     
     
     
281. KLEEBAYOON A, Wiwanitkit V
     Letter to the Editor from Kleebayoon and Wiuwanikit: 'Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study'.
     J Clin Endocrinol Metab. 2023 Jul 18:dgad428. doi: 10.1210.
     PubMed    
     
     
     
282. MERCADO M
     The Role of Androgen Receptors in Thyroid Cancer Biology: Beyond Sexual Dimorphism.
     J Clin Endocrinol Metab. 2023 Jul 15:dgad424. doi: 10.1210.
     PubMed    
     
     
     
283. WANG JR, Zafereo ME, Wang W, Joshu C, et al
     Association of polygenic score with tumor molecular subtypes in papillary thyroid carcinoma.
     J Clin Endocrinol Metab. 2023 Jul 15:dgad407. doi: 10.1210.
     PubMed     Abstract available
     
     
     
284. TIAN T, Qi Z, Huang S, Wang H, et al
     Radioactive Iodine Therapy Decreases the Recurrence of Intermediate-Risk PTC With Low Thyroglobulin Levels.
     J Clin Endocrinol Metab. 2023;108:2033-2041.
     PubMed     Abstract available
     
     
     
285. ULDALL TORP NM, Liew Z, Carle A, Karmisholt J, et al
     Hyperthyroidism in Danish pregnant women during a 20-year period.
     J Clin Endocrinol Metab. 2023 Jul 12:dgad410. doi: 10.1210.
     PubMed     Abstract available
     
     
     
286. ROJAS RAMOS JCR, Pelaez JM, Ono SE, Ramos CS, et al
     Cerebral cortical thickness morphometry and neurocognitive correlations in adolescents with congenital hypothyroidism.
     J Clin Endocrinol Metab. 2023 Jul 4:dgad391. doi: 10.1210.
     PubMed     Abstract available
     
     
     
287. NOEL JE, Sinclair CF
     Radiofrequency Ablation for Benign Thyroid Nodules.
     J Clin Endocrinol Metab. 2023 Jul 4:dgad357. doi: 10.1210.
     PubMed     Abstract available
     
     
     June 2023
288. KAHALY GJ, Dolman PJ, Wolf J, Giers BC, et al
     Proof-of-Concept and Randomized, Placebo-Controlled Trials of an Fcrn Inhibitor, Batoclimab, for Thyroid Eye Disease.
     J Clin Endocrinol Metab. 2023 Jun 30:dgad381. doi: 10.1210.
     PubMed     Abstract available
     
     
     
289. KESBY N, Mechera R, Fuchs T, Papachristos A, et al
     Response to Letter to the Editor From Devgan and Mayilvaganan: 'Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma'.
     J Clin Endocrinol Metab. 2023 Jun 28:dgad380. doi: 10.1210.
     PubMed    
     
     
     
290. DEVGAN Y, Mayilvaganan S
     Letter to the Editor from Devgan and Mayilvaganan: 'Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma'.
     J Clin Endocrinol Metab. 2023 Jun 28:dgad379. doi: 10.1210.
     PubMed    
     
     
     
291. SCHOLFIELD DW, Lopez J, Eagan A, Antal Z, et al
     Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?
     J Clin Endocrinol Metab. 2023 Jun 23:dgad369. doi: 10.1210.
     PubMed     Abstract available
     
     
     
292. PLEIC N, Gunjaca I, Babic Leko M, Zemunik T, et al
     Thyroid function and metabolic syndrome: a two-sample bidirectional Mendelian randomization study.
     J Clin Endocrinol Metab. 2023 Jun 20:dgad371. doi: 10.1210.
     PubMed     Abstract available
     
     
     
293. HA EK, Kim JH, Cha HR, Lee GC, et al
     Assessment of neurodevelopment and growth in congenital hypothyroidism: Serial 6-year follow-up study of 408 patients.
     J Clin Endocrinol Metab. 2023 Jun 19:dgad364. doi: 10.1210.
     PubMed     Abstract available
     
     
     
294. SHAHA AR
     Aggressive Subtypes of Papillary Microcarcinoma.
     J Clin Endocrinol Metab. 2023;108:e489-e490.
     PubMed    
     
     
     
295. XIANG P, Ahmadi S, Coleman A, West W, et al
     Identifying and Predicting Diverse Patterns of Benign Nodule Growth.
     J Clin Endocrinol Metab. 2023;108:e458-e463.
     PubMed     Abstract available
     
     
     
296. ETTLESON MD, Ibarra S, Wan W, Peterson S, et al
     Demographic, healthcare access, and dietary factors associated with thyroid hormone treatments for hypothyroidism.
     J Clin Endocrinol Metab. 2023 Jun 16:dgad331. doi: 10.1210.
     PubMed     Abstract available
     
     
     
297. YEH MW
     The molecular landscape of thyroid nodules: Diagnostic and prognostic revelations from a large multicenter cohort.
     J Clin Endocrinol Metab. 2023 Jun 15:dgad362. doi: 10.1210.
     PubMed    
     
     
     
298. YAN L, Zhen Y, Li Y, Li X, et al
     Five-year Outcome Between Radiofrequency Ablation vs. Surgery for Unilateral Multifocal Papillary Thyroid Microcarcinoma.
     J Clin Endocrinol Metab. 2023 Jun 15:dgad360. doi: 10.1210.
     PubMed     Abstract available
     
     
     
299. MORAN C, Chatterjee K
     Maternal Resistance to Thyroid Hormone beta and pregnancy outcomes.
     J Clin Endocrinol Metab. 2023 Jun 14:dgad350. doi: 10.1210.
     PubMed    
     
     
     
300. YUAN J, Liu X, Wang X, Zhou H, et al
     Association Between Educational Attainment and Thyroid Function: Results from Mendelian randomization and NHANES study.
     J Clin Endocrinol Metab. 2023 Jun 7:dgad344. doi: 10.1210.
     PubMed     Abstract available
     
     
     
301. SATAPATHY S, Majeed AK, Ballal S, Bal C, et al
     Differentiated thyroid cancers in young adults versus children: Clinical characteristics and ten-year follow-up outcomes.
     J Clin Endocrinol Metab. 2023 Jun 7:dgad343. doi: 10.1210.
     PubMed     Abstract available
     
     
     
302. DANNER E, Jaaskelainen J, Niuro L, Huopio H, et al
     Comorbidity in congenital hypothyroidism - A nationwide population-based cohort study.
     J Clin Endocrinol Metab. 2023 Jun 6:dgad334. doi: 10.1210.
     PubMed     Abstract available
     
     
     
303. CATTONI A, Molinari S, Capitoli G, Masera N, et al
     Thyroid Function Tests in Children and Adolescents with Trisomy 21: Definition of Syndrome-Specific Reference Ranges.
     J Clin Endocrinol Metab. 2023 Jun 3:dgad333. doi: 10.1210.
     PubMed     Abstract available
     
     
     
304. ZHOU Y, Wang Y, Zhang Z, Yin X, et al
     Male sex is not a risk factor for prognosis in postoperative thyroid cancer patients: a propensity score matching study.
     J Clin Endocrinol Metab. 2023 Jun 2:dgad314. doi: 10.1210.
     PubMed     Abstract available
     
     
     
305. SGRO D, Brancatella A, Greco G, Torregrossa L, et al
     Cytological and Ultrasound Features of Thyroid Nodules Correlate with Histotypes and Variants of Thyroid Carcinoma.
     J Clin Endocrinol Metab. 2023 Jun 2:dgad313. doi: 10.1210.
     PubMed     Abstract available
     
     
     
306. BOJARSKY M, Baran JA, Halada S, Isaza A, et al
     Outcomes of ATA Low-Risk Pediatric Thyroid Cancer Patients Not Treated with Radioactive Iodine Therapy.
     J Clin Endocrinol Metab. 2023 Jun 2:dgad322. doi: 10.1210.
     PubMed     Abstract available
     
     
     May 2023
307. LIN Y, Wu ZR, Shi YP, Ding M, et al
     Radiofrequency Ablation of Unifocal Papillary Thyroid Microcarcinoma With BRAF V600E Mutation.
     J Clin Endocrinol Metab. 2023 May 23:dgad269. doi: 10.1210.
     PubMed     Abstract available
     
     
     
308. CHOU CK, Chi SY, Hung YY, Yang YC, et al
     Clinical impact of androgen receptor-suppressing miR-146b expression in papillary thyroid cancer aggressiveness.
     J Clin Endocrinol Metab. 2023 May 23:dgad279. doi: 10.1210.
     PubMed     Abstract available
     
     
     
309. CARLOMAGNO F, Minnetti M, Angelini F, Pofi R, et al
     Altered thyroid feedback loop in Klinefelter syndrome: a cohort study from infancy through the transition into adulthood.
     J Clin Endocrinol Metab. 2023 May 22:dgad281. doi: 10.1210.
     PubMed     Abstract available
     
     
     
310. ALZAHRANI AS
     Clinical use of molecular data in thyroid nodules and cancer.
     J Clin Endocrinol Metab. 2023 May 18:dgad282. doi: 10.1210.
     PubMed     Abstract available
     
     
     
311. MINASSIAN C, Allen LA, Okosieme O, Vaidya B, et al
     Preconception management of hyperthyroidism and thyroid status in subsequent pregnancy: a population-based cohort study.
     J Clin Endocrinol Metab. 2023 May 18:dgad276. doi: 10.1210.
     PubMed     Abstract available
     
     
     
312. MULLER NA, Kaegi-Braun N, Durmisi M, Gressies C, et al
     Low T3 Syndrome on Admission and Response to Nutritional Support in Malnourished Medical Inpatients.
     J Clin Endocrinol Metab. 2023;108:e240-e248.
     PubMed     Abstract available
     
     
     
313. WRIGHT JJ, Johnson DB
     Approach to the Patient With Immune Checkpoint Inhibitor-Associated Endocrine Dysfunction.
     J Clin Endocrinol Metab. 2023;108:1514-1525.
     PubMed     Abstract available
     
     
     
314. NASR CE, Andrioli M, Endo M, Harrell RM, et al
     Real-World Performance of the Afirma Genomic Sequencing Classifier (GSC)-A Meta-analysis.
     J Clin Endocrinol Metab. 2023;108:1526-1532.
     PubMed     Abstract available
     
     
     
315. RHEE CM, You AS, Narasaki Y, Brent GA, et al
     Development and Validation of a Prediction Model for Incident Hypothyroidism in a National Chronic Kidney Disease Cohort.
     J Clin Endocrinol Metab. 2023 May 15:dgad261. doi: 10.1210.
     PubMed     Abstract available
     
     
     
316. ZHANG Q, Jiao X, Lai X
     Clinical characters and influence factors of immune checkpoint inhibitor related thyroid dysfunction.
     J Clin Endocrinol Metab. 2023 May 15:dgad260. doi: 10.1210.
     PubMed     Abstract available
     
     
     
317. SUN Y, Sun Q, Tian J, He X, et al
     Impact of waiting time for radioactive iodine therapy on outcome in N1 stage papillary thyroid cancer.
     J Clin Endocrinol Metab. 2023 May 11:dgad264. doi: 10.1210.
     PubMed     Abstract available
     
     
     
318. INOUE K, Guo R, Lee ML, Ebrahimi R, et al
     Iodine-Induced Hyperthyroidism and Long-term Risks of Incident Atrial Fibrillation and Flutter.
     J Clin Endocrinol Metab. 2023 May 5:dgad250. doi: 10.1210.
     PubMed     Abstract available
     
     
     April 2023
319. LANG X, Zhao B, Fang S, Li L, et al
     Higher peripheral thyroid sensitivity is linked to a lower risk of heart failure after acute myocardial infarction.
     J Clin Endocrinol Metab. 2023 Apr 27:dgad240. doi: 10.1210.
     PubMed     Abstract available
     
     
     
320. MUKHOPADHYAY P, Ghosh S
     Letter to the Editor From Mukhopadhyay and Ghosh: "The Use of Levothyroxine Absorption Tests in Clinical Practice".
     J Clin Endocrinol Metab. 2023 Apr 26:dgad239. doi: 10.1210.
     PubMed    
     
     
     
321. BATMAN A, Yazici D, Dikbas O, Agbaht K, et al
     Subacute THYROiditis Related to SARS-CoV-2 VAccine and Covid-19 (THYROVAC Study): A Multicenter Nationwide Study.
     J Clin Endocrinol Metab. 2023 Apr 25:dgad235. doi: 10.1210.
     PubMed     Abstract available
     
     
     
322. ULLMANN TM, Sosa JA
     Delay in Surgery for Papillary Thyroid Cancer: A Proxy for Lower-Quality Care?
     J Clin Endocrinol Metab. 2023 Apr 21:dgad232. doi: 10.1210.
     PubMed    
     
     
     
323. ZHOU X, Iwama S, Kobayashi T, Ando M, et al
     The risk of thyroid dysfunction in PD-1 blockade is stratified by the pattern of TgAb and TPOAb positivity at baseline.
     J Clin Endocrinol Metab. 2023 Apr 21:dgad231. doi: 10.1210.
     PubMed     Abstract available
     
     
     
324. CHIOSEA S, Hodak SP, Yip L, Abraham D, et al
     Molecular Profiling of 50,734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management.
     J Clin Endocrinol Metab. 2023 Apr 18:dgad220. doi: 10.1210.
     PubMed     Abstract available
     
     
     
325. BIONDI B, Celi FS, McAninch EA
     Critical Approach to Hypothyroid Patients with Persistent Symptoms.
     J Clin Endocrinol Metab. 2023 Apr 18:dgad224. doi: 10.1210.
     PubMed     Abstract available
     
     
     March 2023
326. ALSWAILEM M, Alghamdi B, Alotaibi A, Aljomiah A, et al
     Molecular genetics of diffuse sclerosing papillary thyroid cancer.
     J Clin Endocrinol Metab. 2023 Mar 30:dgad185. doi: 10.1210.
     PubMed     Abstract available
     
     
     
327. KIM NE, Raghunathan RS, Hughes EG, Longstaff XR, et al
     Bethesda III and IV Thyroid Nodules Managed Nonoperatively after Molecular Testing with Afirma GSC or Thyroseq v3.
     J Clin Endocrinol Metab. 2023 Mar 30:dgad181. doi: 10.1210.
     PubMed     Abstract available
     
     
     
328. ALZAHRANI AS
     The risk of expanding risk stratification in thyroid cancer.
     J Clin Endocrinol Metab. 2023 Mar 29:dgad182. doi: 10.1210.
     PubMed    
     
     
     
329. CHAVES N, Broekhuis JM, Fligor SC, Collins RA, et al
     Delay in Surgery and Papillary Thyroid Cancer Survival in the United States: a SEER-Medicare Analysis.
     J Clin Endocrinol Metab. 2023 Mar 29:dgad163. doi: 10.1210.
     PubMed     Abstract available
     
     
     
330. TAYLOR P, Rajendram R, Hanna S, Wilson V, et al
     Factors predicting long-term outcome and the need for surgery in Graves Orbitopathy: extended follow-up from the CIRTED Trial.
     J Clin Endocrinol Metab. 2023 Mar 27:dgad084. doi: 10.1210.
     PubMed     Abstract available
     
     
     
331. VAN VELSEN EFS, Verburg FA
     Adjuvant Radioiodine for Intermediate-Risk Papillary Thyroid Cancer - To Treat or Not To Treat.
     J Clin Endocrinol Metab. 2023 Mar 25:dgad171. doi: 10.1210.
     PubMed    
     
     
     
332. KESBY N, Mechera R, Fuchs T, Papachristos A, et al
     Natural History and Predictive Factors of Outcome in Medullary Thyroid Microcarcinoma.
     J Clin Endocrinol Metab. 2023 Mar 25:dgad173. doi: 10.1210.
     PubMed     Abstract available
     
     
     
333. MARIN L, Sabbadin C, Armanini D, Ambrosini G, et al
     Letter to the editor from Marin et al.: "The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography".
     J Clin Endocrinol Metab. 2023 Mar 23:dgad170. doi: 10.1210.
     PubMed    
     
     
     
334. MATHEWS DM, Peart JM, Sim RG, Johnson NP, et al
     Response to Letter to the Editor by Marin etal: "The SELFI Study: Iodine Excess and Thyroid Dysfunction in Women Undergoing Oil-Soluble Contrast Hysterosalpingography".
     J Clin Endocrinol Metab. 2023 Mar 23:dgad169. doi: 10.1210.
     PubMed    
     
     
     
335. NASR CE
     Can one predict long-term growth of cytologically-benign thyroid nodules?
     J Clin Endocrinol Metab. 2023 Mar 22:dgad160. doi: 10.1210.
     PubMed    
     
     
     
336. JHA S, Welch J, Tora R, Lack J, et al
     Germline and somatic inactivating FLCN variants in parathyroid cancer and atypical parathyroid tumors.
     J Clin Endocrinol Metab. 2023 Mar 20:dgad136. doi: 10.1210.
     PubMed     Abstract available
     
     
     
337. CARON P, Decleves X
     The use of levothyroxine absorption tests in clinical practice.
     J Clin Endocrinol Metab. 2023 Mar 14:dgad132. doi: 10.1210.
     PubMed     Abstract available
     
     
     
338. AMARIKWA L, Mohamed A, Kim SH, Kossler AL, et al
     Teprotumumab-Related Hyperglycemia.
     J Clin Endocrinol Metab. 2023;108:858-864.
     PubMed     Abstract available
     
     
     
339. LEVAILLANT L, Bouhours-Nouet N, Illouz F, Jager JA, et al
     The Severity of Congenital Hypothyroidism with Gland-in-situ Predicts Molecular Yield by Targeted NGS.
     J Clin Endocrinol Metab. 2023 Mar 8:dgad119. doi: 10.1210.
     PubMed     Abstract available
     
     
     
340. TIAN Y, Yao D, Jin A, Wang M, et al
     Thyroid function in causal relation to MRI markers of cerebral small vessel disease: a Mendelian randomization analysis.
     J Clin Endocrinol Metab. 2023 Mar 7:dgad114. doi: 10.1210.
     PubMed     Abstract available
     
     
     February 2023
341. POIRIER J, Godemel S, Mourot A, Grunenwald S, et al
     Central Hypothyroidism is Frequent During Mitotane Therapy in Adrenocortical Cancer Patients: Prevalence and Timeline.
     J Clin Endocrinol Metab. 2023 Feb 28:dgad115. doi: 10.1210.
     PubMed     Abstract available
     
     
     
342. 
     Retraction to "Thyroid Cancer Cell Resistance to Gefitinib Depends on the Constitutive Oncogenic Activation of the ERK Pathway".
     J Clin Endocrinol Metab. 2023 Feb 28:dgad056. doi: 10.1210.
     PubMed    
     
     
     
343. WONG CH, Leung EKH, Tang LCK, Lee CH, et al
     Response Letter to the Editor from Zhang et al.: 'Effect of inactivated and mRNA COVID-19 vaccination on thyroid function among patients treated for hyperthyroidism'.
     J Clin Endocrinol Metab. 2023 Feb 27:dgad093. doi: 10.1210.
     PubMed    
     
     
     
344. ZHANG Y, Zhu S, Gao Y
     Letter to the Editor from Zhang et al.: 'Effect of inactivated and mRNA COVID-19 vaccination on thyroid function among patients treated for hyperthyroidism'.
     J Clin Endocrinol Metab. 2023 Feb 27:dgad094. doi: 10.1210.
     PubMed    
     
     
     November 2022
345. DOTTORE GR, Lanzolla G, Comi S, Menconi F, et al
     Insights into the role of DNA methylation and gene expression in Graves' orbitopathy.
     J Clin Endocrinol Metab. 2022 Nov 6. pii: 6806119. doi: 10.1210.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.